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An Analysis of the Differences in Preemptive Kidney Transplantation Between
Blacks and Whites
Abstract
Background. This cohort study investigates whether there are inequities in the allocation of cadaver
kidneys for preemptive kidney transplants (PKT) between blacks and whites.
Methods. This analysis uses descriptive statistics and univariate and multivariate analyses to identify
factors associated with the determination of whether a patient receives a PKT or a conventional, post
dialysis kidney transplant. The sample includes patients identified by the Centers for Medicare and
Medicaid Services (CMS) as having end stage renal disease (ESRD), >19 years of age, either black or
white, and receiving either a PKT (0-<6 months>dialysis) or conventional transplant between January 1,
2000 and December 31, 2003 (n = 10,067) from any of the 11 organ procurement regions in the United
States.
Results. Whites were more likely to receive a PKT (p<0.05). Females were 23% more likely to receive a
preemptive kidney transplant as males. Those without hypertension as the primary cause of ESRD were
more than 3 times more likely to receive a PKT. Those without diabetes as the primary cause of ESRD
were as than 2 times more likely to receive a PKT. Those without glomerulonephritis as the primary cause
of ESRD were more than 2 times as likely to receive a PKT. Interestingly, this research shows that the
leading causes of ESRD in blacks and whites who received PKTs was diabetes, 22% and 31% respectively.
Black conventional transplant recipients had higher rates of hypertension and diabetes than did black
PKT recipients overall. White conventional kidney transplant recipients had the highest rates of diabetes
(39.19%) of all groups. Of all PKT recipients, blacks received 10.76% compared with 89.24% received by
whites. The mean age for blacks receiving PKTs was 48.4 years of age compared with 47 years of age for
black conventional kidney transplant recipients. The mean age for whites, both PKT and conventional
transplant recipients was approximately 49 years of age. Higher percentages of PKTs took place in the
northeastern and southeastern regions (UNOS regions 2 and 3) of the United States. The majority of PKT
recipients, both blacks and whites, received their donor organs from whites. Blacks received 69.42% white
donor, organs compared with 77.61% received by whites. Blacks did receive 17.43% of their donor organs
from blacks, with whites receiving approximately 6% of their organs from blacks. For those receiving PKTs
during the study period, 86% of whites and 81% of blacks were still alive with functioning grafts at the
conclusion of the study period. Medicare A and B as the primary insurance and those who had Medicare
as a secondary payer each did reflect statistical significance as indicators of being less likely than
patients insured otherwise.
Conclusion. From this analysis it is concluded that a disparity exists in the allocation of PKTs between
blacks and whites. These results indicate that blacks are less likely to receive a PKT than their white ESRD
counterparts, females are more likely to receive a preemptive kidney transplant than males, and that both
males and females are more likely to receive a PKT if they do not have a diagnosis as the primary cause
of their ESRD of hypertension, diabetes and/or glomerulonephritis. These results suggest that there may
be remediable inequities in the current system relating to the policies of UNOS and that PKTs can be
allocated in a more equitable manner.
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ABSTRACT

Background. This cohort study investigates whether there are inequities in the
allocation of cadaver kidneys for preemptive kidney transplants (PKT) between blacks and
whites.
Methods. This analysis uses descriptive statistics and univariate and multivariate
analyses to identify factors associated with the determination of whether a patient receives a
PKT or a conventional, post dialysis kidney transplant. The sample includes patients
identified by the Centers for Medicare and Medicaid Services (CMS) as having end stage
renal disease (ESRD), >19 years of age, either black or white, and receiving either a PKT (0<6 months dialysis) or conventional transplant between January 1, 2000 and December 31,
2003 (n = 10,067) from any of the 11 organ procurement regions in the United States.
Results. Whites were more likely to receive a PKT (p<0.05). Females were 23%
more likely to receive a preemptive kidney transplant as males. Those without hypertension
as the primary cause of ESRD were more than 3 times more likely to receive a PKT. Those
without diabetes as the primary cause of ESRD were as than 2 times more likely to receive a
PKT. Those without glomerulonephritis as the primary cause of ESRD were more than 2
times as likely to receive a PKT. Interestingly, this research shows that the leading causes of
ESRD in blacks and whites who received PKTs was diabetes, 22% and 31% respectively.
Black conventional transplant recipients had higher rates of hypertension and diabetes than
did black PKT recipients overall. White conventional kidney transplant recipients had the
highest rates of diabetes (39.19%) of all groups. Of all PKT recipients, blacks received
10.76% compared with 89.24% received by whites. The mean age for blacks receiving PKTs
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was 48.4 years of age compared with 47 years of age for black conventional kidney
transplant recipients. The mean age for whites, both PKT and conventional transplant
recipients was approximately 49 years of age. Higher percentages of PKTs took place in the
northeastern and southeastern regions (UNOS regions 2 and 3) of the United States. The
majority of PKT recipients, both blacks and whites, received their donor organs from whites.
Blacks received 69.42% white donor, organs compared with 77.61% received by whites.
Blacks did receive 17.43% of their donor organs from blacks, with whites receiving
approximately 6% of their organs from blacks. For those receiving PKTs during the study
period, 86% of whites and 81% of blacks were still alive with functioning grafts at the
conclusion of the study period. Medicare A and B as the primary insurance and those who
had Medicare as a secondary payer each did reflect statistical significance as indicators of
being less likely than patients insured otherwise.
Conclusion. From this analysis it is concluded that a disparity exists in the allocation
of PKTs between blacks and whites. These results indicate that blacks are less likely to
receive a PKT than their white ESRD counterparts, females are more likely to receive a
preemptive kidney transplant than males, and that both males and females are more likely to
receive a PKT if they do not have a diagnosis as the primary cause of their ESRD of
hypertension, diabetes and/or glomerulonephritis.

These results suggest that there may be

remediable inequities in the current system relating to the policies of UNOS and that PKTs
can be allocated in a more equitable manner.
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CHAPTER 1. INTRODUCTION

The first successful kidney transplant performed by Dr. Joseph Murray took place
over 50 years ago. Subsequently, the field of kidney transplantation has continued to evolve,
and long-term survival following transplantation has surpassed survival on dialysis for all
races (Wolf, et al., 1999). Renal transplantation reduces mortality, improves quality of life,
and is less costly than dialysis (Kasiske, et al., 2000). The benefits of kidney transplantation
have been shown regardless of recipient sex, race, age, or cause of end stage renal disease
(ESRD) (Wolf et al., 1999). The benefits of preemptive kidney transplantation (PKT) have
shown it to be the optimal strategy to benefit patients requiring renal replacement therapy
(Wolf, et al., 1999). Although both blacks and whites have benefited from these advances, it
remains unfortunate that use of these life-prolonging modalities is not equivalent among all
races; also equivalent success eludes blacks who are disadvantaged in gaining kidney
transplants. Constituting almost half of those waiting for a renal transplant, blacks receive
less than 28% of all cadaver-donor kidneys each year and an even smaller percentage of PKT
before the initiation of maintenance dialysis (Young & Kew, 2005).
Kidney transplantation has historically taken place after a variable period of dialysis
therapy. The optimal timing of kidney transplantation and the question of whether one
receives a transplant preemptively or begins routine dialysis maintenance is the subject of
much controversy (Katz et al., 1991; Roake et al., 1996). The debate regarding preemptive
kidney transplantation (PKT) is compounded by the fact that first of all it takes place
contrary to the policies outlined by the United Network for Organ Sharing and secondly it is
hypothesized by this research that since blacks have not historically enjoyed the benefits of
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conventional renal transplantation to the same degree as their white counterparts (Norris &
Agodoa, 2005) they most certainly do not enjoy the relative frequency of PKT as do their
white counterparts. Because blacks are much less likely than whites to be referred for
evaluation at a transplant center, to be placed on a waiting list, or to receive traditional postdialysis transplants (Ayanian et al., 1999), it logically follows that their use of PKT would be
limited as well. Given the disparities blacks have experienced with renal replacement and
the benefits attributed to PKT, the question remains whether blacks will fare any better in the
PKT arena when compared with their white counterparts. The current analysis of data
obtained from the United Network for Organ Sharing (UNOS) and United States Renal Data
system (USRDS) examined the characteristics of patients who received either PKT or
conventional transplants, the effect of PKT or conventional transplants on outcomes, whether
the effects on outcomes were similar in both PKT and conventional transplant patients and
whether these effects were independent of recipients race and/or other factors.

BLACKS AND ESRD
To create a context for the current study’s examination of the disparity in PKT, brief
overviews are provided of the end stage renal disease (ESRD) problem and how blacks now
have such a significant need for transplantation. Chronic kidney disease (CKD) occurs when
the kidneys begin to fail in their ability to excrete wastes, concentrate urine, and regulate
electrolytes. The National Kidney Foundation (NKF) estimates that 20 million Americans
have CKD, and at least 20 million others are at increased risk to develop CKD. End stage
renal disease (ESRD) occurs when the kidneys are no longer able to function at a level
necessary for day-to- day life, which is usually when kidney function drops below 10% of
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normal functioning capacity. During the last decade, the number of ESRD patients in the
United States grew at an exponential rate—doubling from 201,454 in 1991 to 406,081 in
2001 (Norris & Agodoa, 2005). There was a 4.2% increase in the ESRD population between
2000 and 2001 (Szczech & Lazar, 2004). There are projections that the ESRD population
will increase to 700,000 by 2010 and to more than 2 million people by 2030 (Szczech &
Lazar, 2004).
A review of recent data indicates that ESRD occurs nearly four times more frequently
among blacks than their white counterparts, and continues to represent one of the most
dramatic examples of health disparities in our nation (Norris & Agodoa, 2002). The black
population consistently has suffered from a greater than 3.5-fold higher rate of treated ESRD
than the white population. The United States Renal Data System (USRDS) annual report
from 2004 noted that blacks in the United States continued to have a disproportionately
greater incidence and prevalence rate of ESRD (Fig. 1-1) (Agodoa, 2003). The overall
adjusted incidence rate of new black ESRD patients in 2003 was 998 per million population,
compared with 334 per million for whites. This represented a quadrupling of the overall
incidence of ESRD since 1980 (USRDS, 2003).
Correspondingly, the ESRD program has a significant over-representation of blacks.
Although some factors contributing to these alarming rates of ESRD among blacks have been
identified, the exact reasons why these disparities exist have yet to be fully elucidated.
Despite concerted efforts to better understand the causative factors that precipitate renal
disease in blacks, ESRD in the U.S. is likely to remain disproportionately higher in blacks.
As a result, blacks will continue to disproportionately populate dialysis centers and transplant
center waiting lists.
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Figure 1-1. Incidence rates of ESRD due to diabetes, hypertension, and other renal
disease according to ethnicity.
Source: Agodoa L. Lessons from chronic renal diseases in African Americans: Treatment
implications. Ethn Dis 2003;13:S120. Reprinted with permission.

DIABETES MELLITUS
Approximately 70% of all new adult ESRD cases in the United States are attributable
to diabetes and hypertension. Diabetes is the leading cause of ESRD, with
glomerulonephritis and cystic kidney diseases constituting about 10% of cases (see Fig. 1-1)
(Agodoa, 2003). The prevalence of diabetes in black men is nearly 50% greater than in white
men, and black women are 100% more likely to have diabetes than white women (Crook et
al., 2001). An estimated (NHANES III, 1988-1994) 8% of adults in the United States have
type 2 diabetes mellitus (Harris, 1998), and the incidence of this disease is increasing
(USRDS, 2003). The number of cases of diabetes mellitus, and consequently diabetic
nephropathy, is also rising progressively worldwide (King, 1998). Diabetic nephropathy
4

occurs in about one third of patients with diabetes mellitus and is the most common cause of
ESRD in most industrialized nations—accounting for nearly half of new ESRD cases
(USRDS, 2003). Relative to whites, the incidence of diabetes mellitus is 2.3 times higher in
blacks than whites (USRDS, 2003).
Krop et al. (1999) noted that blacks with diabetes mellitus had early renal function
decline three times that of whites. More than 80% of this disparity has been attributed to
lower socioeconomic status, suboptimal health behaviors, and suboptimal control of blood
glucose level and blood pressure. This trend is likely to continue because the incidence of
type 2 diabetes mellitus is fueled by the increasing prevalence of obesity among blacks.

HYPERTENSION
The second most common cause of ESRD is hypertension. The prevalence of
hypertension among blacks in the United States has increased substantially and is the highest
in the world (Coresh et al., 2001). Among young blacks aged 20 to 44 years, the incidence of
hypertension is 20 times higher than that of whites (USRDS 2001, Annual Report). The age
adjusted prevalence of hypertension in blacks is 32.4%, which is nearly 40% higher than
whites (23%) (Burt et al., 1995). The pattern of hypertensive ESRD is unique among blacks;
it has remained a leading cause of ESRD for all ages, from the pediatric group—which is
uncommon in other racial/ethnic groups—through the geriatric black population (Agodoa,
2003). Among several theories that have been proposed to explain the significant
hypertensive rates among blacks is the possibility that environmental and genetic factors
(excess salt intake superimposed on a genetic predisposition to salt retention) may lead to
low-renin hypertension (Warnock, 2000). Blacks may have a predisposition to the
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deleterious effects of hypertension on renal function, even if blood pressures are well
controlled (Hall et al., 1997). Added to these physiologic variables are the socioeconomic
and educational disadvantages often encountered by blacks, many of whom never received
care for their hypertension before developing irreversible kidney failure (Geiger, 1996).
Hypertension is a major contributing factor in the increased prevalence of ESRD seen in the
black population, leading to dialysis or transplantation (UNOS 1999, Annual Report). In
sum, there are proportionately more blacks entering the ESRD network; yet, as a group, they
are significantly under-represented in the population receiving renal transplants (Young &
Kew, 2005).
Although diabetes, hypertension, and some of the other factors contributing to the
alarming rates of ESRD among blacks have been identified, the reasons for the disparities in
transplantation rates between blacks and whites have yet to be fully explained. For the time
being it appears that ESRD is likely to remain disproportionately higher in blacks and,
therefore, result in many more blacks remaining on dialysis and awaiting kidney transplants.

DIALYSIS
A disproportionate number of black patients receive hemodialysis as the treatment
modality for renal replacement therapy. Data from the USRDS in 1999 revealed that black
patients had the highest incidence of hemodialysis among all racial or ethnic populations
(Gadegbeku, Freeman & Lawrence, 2002). Although dialysis is life prolonging, extended
periods on dialysis are detrimental to subsequent renal allograft survival. Furthermore, late or
emergency referral to dialysis, which is associated with three-fold higher mortality and
morbidity rates, longer and more expensive hospital stays (Roubicek, Brunet & Huiart,

6

2000), is more likely to occur in blacks than whites. Lower levels of kidney function at
initiation of dialysis appear to a greater extent in blacks than in other racial groups (Kausz et
al., 2000). Even when dialysis is undertaken, despite the clear guidelines for hemodialysis
dose and monitoring, the prescribed dose is more likely to be suboptimal in black
hemodialysis patients (Owen et al., 1998).
Because of the increasing incidence and prevalence of ESRD there is an ever
increasing shortage of kidneys for transplantation. As a result of this shortage combined with
additional pathophysiological factors, blacks are less likely to receive a transplanted kidney
than are their white counterparts. This diminished likelihood of receiving a transplant has
been linked to nephrologists’ delaying referral of blacks for transplantation and the
diminished likelihood of their being placed on the UNOS waiting list (Roizon-Solomon &
Burrows, 1999). As a result, most blacks with ESRD receive hemodialysis to perform the
work of their diseased kidneys.
Despite the hefty representation of blacks on hemodialysis, the annual death rate was
181/100 patient years, lower than the 284.7/1000 patient years for whites (USRDS, 2002).
The lower rate has been attributed to blacks fairing better than whites on dialysis; however,
this conclusion may be incorrect. Because blacks on hemodialysis tend to be younger, a
possible explanation for this difference in death rats is that blacks on dialysis are healthier
than whites on dialysis and are better able to withstand dialysis treatment. In 2002, 54% of
patients on dialysis under age 50 years old were black; this percentage decreased to 39% for
those over age 50 years (USRDS, 2002). It follows that blacks who are suitable candidates
for renal transplantation are not being transplanted but are waiting on dialysis. Conversely,
the older, less healthy, and more likely un-transplantable patients (older whites with co-
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morbidities) are dying on dialysis and possibly creating the false impression that death rates
are higher. Between 1997 and 2000, 49,963 cadaver donor renal transplants took place in the
United States (Young & Kew, 2005). Of these allograft, 35,532 (71%) were transplanted
into whites, whereas 11,667 (23%) went to blacks. Therefore, it was surmised that the
decrease in the proportion of whites in the prevalent population was mainly due to their
referral for renal transplantation and not patient death (Agodoa, 2003).

TRANSPLANTATION AND HLA MATCHING
On December 23, 1954, the first successful human organ transplant was performed.
A kidney was transplanted from a living donor who was an identical twin of the recipient.
Because immunosuppressive therapy had not evolved to its current state, there was no
consideration given to the use of cadaver organs. The burden for finding a suitable living
donor rested with those in need of organs. There was no waiting list and no apparent
shortage of organs (Barnett & Kaserman, 2000). Not long after the first successful
transplant, improved tissue matching made transplantation of cadaver kidneys possible. In
1972 the ESRD program, which was administered by the Social Security Administration,
extended federal insurance coverage to kidney transplantation and dramatically increased the
demand for cadaver organs. This change led to a shift in kidney procurement policy, from
focusing exclusively upon living related donors to the procurement of cadaver organs from
unrelated donors. The kidney transplant waiting list managed by health professionals at local
transplant centers, began to form in the late 1970s putting pressure on scientists to find ways
to alleviate the shortage of transplantable kidneys. Given the predominantly white donor
population in the United States, black ESRD patients were at an obvious disadvantage in
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their chances of receiving a suitable kidney. This situation was and continues to be
compounded by lower levels of organ donation among blacks due, at least in part, to many
cultural factors (Epstein et al., 2000).
Research shows that blacks are less likely than white patients to be considered
appropriate candidates for transplantation (9% versus 21%, respectively) and that blacks
continue to be more likely to have an incomplete transplant workup (47% versus 39%)
(Epstein et al., 2000). The most common reasons offered for blacks being considered
inappropriate for transplantation were a body mass index over 35, presence of an active
infection and presence of extra-renal, non-cardiac co-morbidities. Even after candidacy is
established among patients considered suitable for a transplant, blacks still remain at a
disadvantage and are still less likely than whites to actually receive a transplant (17% vs.
52%, respectively) (Epstein et al., 2000).
The United Network for Organ Sharing (UNOS) allocation policy mandates ABO
blood type identity. Although this is a necessary policy, black candidates, by nature
of the donor pool (predominantly white), are disadvantaged by a predilection for ABO
blood types associated with longer waits (Epstein et al., 2000). Another important facet in
determining who receives a kidney transplant is the relative weight given the anti-major
histocompatibility complex (MHC) matching in the former UNOS allocation algorithm
(Table 1-1). Wait-listed transplant candidates accumulate ‘‘points.’’ When a kidney
becomes available, the medically suitable candidate with the most points is designated to
receive the organ. Based on the assumption that similarity in MHC antigen expression (i.e.,
matching) between donor and recipient optimizes outcomes, matching was the predominant
variable determining allocation of deceased-donor kidneys (Norman, 1995). The primary
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Table 1-1. Former renal allocation point system for allocating cadaver kidneys in the
United States.
Criterion
Zero antigen mismatch
MHC mismatches
0 BDR
1 BDR
2 BDR
Presensitization
Panel reactive antibody  80%
Waiting time
Longest wait (then fractional)
Each year on list
Age
<11 y
11-18 y

Points
Awarded
mandatory share
7
5
2
4
1
1
4
3

Source: Young, C.J., Kew C. Health disparities in transplantation: focus on the complexity
and challenge of renal transplantation in African Americans. Med Clin N Am 2005; 89:100331.
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benefit of this allocation algorithm was unintentionally conferred on the predominantly white
recipients of completely matched grafts, with marginal impact on outcomes across other
match grades, especially among black recipients. This trend was recognized over a decade
ago with few inter-racial transplants occurring with greater than three (of six) matched MHC
alleles (Lazda, 1992).
Takemoto et al. (2000) reviewed the UNOS database from 1987 to September 1999
under the UNOS allocation algorithm to determine the efficacy of sharing HLA matched
kidneys. Although blacks benefited from this sharing, they received only 8% of the 7,614
matched kidneys. Conversely, 30% of mismatched kidneys went to blacks, approximating the
frequency with which blacks appeared on the wait list (Scantlebury et al., 1998). Even the
proponents of the former allocation system conceded that racial disparity existed (Takemoto
et al., 2000). This fact was made more unacceptable when improved immunosuppressive
medications reduced the impact of matching on allograft survival (Cecka, 1999). The core of
the former point system was implemented in the 1980s when demonstrable incremental
benefit of improved HLA compatibility between donor and recipient was evident. Now, at
least two groups of investigators estimate that the overall benefit of improved HLA
compatibility between donor and recipient is relatively small, improving graft survival by
only 1%–2% (Held et al., 1994; Feldman et al., 1997).
In addition, early reports documented no statistical benefit of matching among blacks,
a finding attributed to the difficulty of obtaining enough good matches in this population for
meaningful analysis (Takemoto et al., 1994). Current data indicate a benefit for blacks of
5%–6% (in graft survival at 3 years) in the few patients able to receive completely matched
grafts, and improvement in allograft half-life from 5.4 to 8.4 years (the latter still being less
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than the years expected for white recipients of mismatched kidneys) (Scantlebury et al.,
1998).
A new UNOS renal allocation scheme was implemented in May 2003 to address
discrepancies in kidney allocation that result from a heterogeneous HLA donor and recipient
population (Table 1-2). Implementation of this new scheme has been an important step in
rectifying the disparity in allocation of kidney transplants among black and white transplant
candidates. Inasmuch as the former UNOS algorithm perpetuated ethnic disparities, major
changes have occurred while preserving mandatory sharing of phenotypically identical
(completely matched) kidneys because it improves transplant outcomes and, despite
identifiable adverse impact on access for blacks, removes relatively few organs from the
overall pool (Young & Kew, 2005).
Beyond phenotypic identity, allocation of points for ‘‘partial’’ matching was
determined indefensible. A 1995 analysis confirmed that ‘‘matching points’’ were
accumulated disproportionately by whites and awarded for match quality that produced
outcomes no better (two mismatches) or worse (three mismatches) than the national average
(Meier-Kriesche, et al., 2000). In response, the algorithm was modified to its current form.
The impact of these modifications on access for blacks is being assessed (Young & Kew,
2005). A recent regional study involving the New England Organ Bank documented that
elimination of points for partial matching indeed improved access for blacks without
compromising outcomes (Delmonico, et al., 1999). Other modifications are possible.
Currently, UNOS allows local variances based on the concept of acceptable
mismatches that preserve the benefits of matching while offering more equitable allocation.
Although some investigators remain unenthusiastic about the potential benefit of such an
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Table 1-2. Current United Network for Organ Sharing Organ Allocation Point
System for allocating cadaver kidneys in the United States.

Criterion
Zero antigen mismatch
MHC mismatches
0 BDR
1 BDR
2 BDR
Presensitization
Panel reactive antibody  80%
Waiting time
Longest wait (then fractional)
Each year on list
Age
<11 y
11-18 y

Points
Awarded
mandatory share
2
1
0
4
1
1
4
3

Source: Young, C.J., Kew C. Health disparities in transplantation: focus on the complexity
and challenge of renal transplantation in African Americans. Med Clin N Am 2005; 89:100331.
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approach, prospective evaluation of its merits is pending. Alternatively, in light of increasing
recognition of the influence of non-immunologic factors (particularly early graft function and
donor age) on long-term survival, it may be time to formulate a completely new paradigm for
organ allocation, especially in light of the success that has been achieved with PKT.

PREEMPTIVE KIDNEY TRANSPLANTATION
Transplantation is recognized as preemptive if it takes place before the initiation of
chronic maintenance dialysis. PKT is an appealing option for patients who are approaching
end stage renal failure but who have not yet progressed to dialysis. Theoretical advantages
include avoiding the inconvenience of frequent hemodialysis sessions or frequent exchanges
of peritoneal fluid, the significant morbidity associated with multiple access procedures, the
risk related to repeated blood transfusions, and the complications of prolonged uremia
(Papalois et al., 2000). In addition, preemptive transplantation eliminates the substantial cost
of dialysis.
In the past there was some concern that this strategy might be associated with an
increased risk of graft loss from rejection, because these patients would not experience the
immunosuppressive effects of uremia. In addition, it has been suggested that compliance
after transplantation might be reduced if the patients had not experienced dialysis as the first
modality of renal replacement therapy. However, a number of recent reports indicate that
PKT gives the clear benefits of not only avoidance of morbidity associated with dialysis and
reduced cost of renal replacement therapy but also significant increases in both patient and
graft survival (Roake et al., 1996). PKT decreased the rate of allograft failure by 25% for
cadaver donor transplants (Kasiske et al., 2002). The basis for the allograft survival
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advantage in preemptive recipients is unclear. Possibilities include a lead time bias due to
the earlier transplantation of patients with preserved native kidney function, less rapid loss of
kidney function after transplantation, or the longer patient survival of PKT recipients.
Despite the success of PKT in reducing the rate of allograft failure, it accounts for only 7% to
8% of cadaver donor transplants (Kasiske et al., 2002).
While it is hypothesized that the lower rate of PKT among cadaver donor transplants
likely resulted from the prolonged duration of time waiting for a cadaver donor, this
hypothesis is not supported by the literature. Previous studies using national data from the
UNOS transplant registry have associated socioeconomic characteristics with rates of
placement on the cadaver waiting list (Kasiske et al., 1998) and with the likelihood of
receiving a cadaver renal transplant before the initiation of dialysis (Kasiske et al., 2002).
Although these results have been informative, analysis of the UNOS registry does not allow
for determination of the factors that affect the decision and timing of either PKT or
placement on the waiting list.
Other studies have examined data exclusively from patients already on dialysis and,
therefore, were not designed to address reasons associated with transplant evaluation before
dialysis initiation (Alexander & Sehgal, 1998; Ayanian et al., 1999; Winkelmayer et al.,
2002). The factors that influence the decision to designate patients for PKT or dialysis are
not well understood. Given the importance of the timing of PKT, the current study was
performed to understand the factors that contribute to preemptive versus non-preemptive
transplantation among persons who experienced renal failure and received a cadaver kidney
transplant during a five year period from 2000 through 2003.
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PROBLEM STATEMENT
Dialysis has long been the established initial choice of therapeutic intervention for
patients with ESRD. However, not only is dialysis associated with significant morbidity and
a greater mortality than transplantation, but it is also expensive. Because of a clear survival
benefit associated with renal transplantation, it has now become generally regarded as the
preferred treatment option for ESRD. Kidney transplant recipients have been shown to live
longer, have a higher quality of life, and consume fewer health care resources compared with
patients on dialysis (Eggers, 1995; Wolfe et al., 1999; Winkelmayer et al., 2002). Kidney
transplantation typically takes place after a period of dialysis. Recently, transplantation
before initiation of dialysis has been advocated because the morbidity and cost of putting in a
stint for dialysis access are avoided. PKT has been associated with an allograft survival
advantage compared with transplantation after initiation of dialysis (Kasiske et al., 2002).
Ethnic disparities in access to renal transplantation are long standing and may be
increasing (Callender, 1991). The incidence of ESRD in blacks is 4 times greater than that in
whites, but blacks remain less likely than whites to be referred for or undergo traditional
post-dialysis renal transplantation (Young & Gaston, 2002). Eggers noted that blacks with
ESRD have limited access to transplantation relative to whites (Eggers, 1988). Blacks
receive only 25% of cadaver kidneys and have a median waiting time for a cadaver kidney
that is twice as long as that of whites (UNOS 1999 Annual Report). Black ESRD patients,
once fully informed of their options, prefer transplantation over dialysis as often as whites
but are significantly less likely to proceed rapidly to transplantation (Young & Gaston,
2002). Broad opinion is that blacks are being referred at a lesser rate than whites for
traditional post-dialysis transplants (Young & Gaston, 2002) and a hypothesis of this
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research is that they are being referred at a lesser rate for PKT as well. The observation that
whites are more likely to be placed on the cadaver waiting list before dialysis initiation and
receive a PKT suggest that there is some systemic bias in determining who receives and does
not receive PKT (Kasiske et al., 1998; Kasiske et al., 2002). The focus of this research was
to attempt to determine if blacks are being afforded PKT at a rate equal to that of whites and,
if not, to determine if there are objective variables that may account for the difference, such
as differences in comorbidities or insurance coverage.

PURPOSE OF THE STUDY
The purpose of this research was to determine whether there are inequities in the
allocation of cadaver kidneys for preemptive kidney transplants (PKT) between blacks and
whites.

RESEARCH OBJECTIVE
The objective of this study was to identify differences between blacks and whites who
experienced kidney failure and received either standard or preemptive cadaver donor kidney
transplants during the four year period between 2000 and 2004. There were three specific
aims:
1. Specific aim 1 was to make a comparison by race of the demographic characteristic
of PKT and conventional transplant recipients.
2. Specific aim 2 was to make a comparison by race of the health state, post transplant
outcomes and time relative to transplantation of PKT and conventional transplant
recipients.
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3. Specific aim 3 was to determine if a racial disparity exists in the receipt of PKT
versus conventional cadaver kidney transplants.

DEFINITIONS OF TERMS AND CONCEPTS
The following were key terms and concepts used in this study:
1. chronic kidney disease (CKD): Term used to describe the whole continuum of
progressive kidney disease, from chronic renal insufficiency (CRI) through and
including end stage renal disease (ESRD).
2. chronic renal insufficiency (CRI): Condition in which the kidneys gradually lose
their ability to perform their primary functions, the removal of wastes and extra fluid
from the body.
3. dialysis: Artificial process of cleaning wastes from the blood when kidneys fail. The
two major forms of dialysis are hemodialysis and peritoneal dialysis.
4. end stage renal disease (ESRD): Total kidney failure that requires dialysis to
remove wastes and fluids from the bloodstream or kidney transplantation. For
purposes of this investigation, ESRD occurs on the date of first service for dialysis.
5. hemodialysis: Use of a machine to clean wastes from the blood after the kidneys
have failed. The blood travels through tubes to a dialyzer, which removes wastes and
extra fluid. The cleaned blood then flows through another set of tubes back into the
body. Hemodialysis is usually performed at a hospital, dialysis clinic, or doctor's
office.
6. peritoneal dialysis: Process by which the blood is cleansed using the lining of the
abdomen as a filter. A cleansing solution, called dialysate, is drained from a bag into
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the abdomen. Fluids and wastes flow through the lining of the abdomen and remain
"trapped" in the dialysate. The dialysate is then drained from the abdomen, removing
the extra fluids and wastes from the body. Typically, peritoneal dialysis can be
performed by the patient at home.
7. pre-emptive kidney transplant (PKT): Process recognized as preemptive if it takes
place before the initiation of chronic dialysis. For the purposes of this investigation
any transplantation which occurred within six months of the date of first service for
dialysis is preemptive.

ASSUMPTIONS
The following assumptions were made regarding this research:
1. The data in the ESRD Program Management and Medical Information System and
the Renal Beneficiary and Utilization System (PMMIS/REBUS) database is reflective
of the actual status of the population that these data represent.
2. The statistical analysis is reliable and valid.
3. Patients were placed on dialysis because of signs, symptoms, and laboratory
indicators of ESRD, and not for other, non-medical reasons.

LIMITATIONS OF THE STUDY
The limitations of this research included the following:
1. The PMMIS/REBUS database is dynamic, and the results reported in the
investigation therefore represent only a cross section of time.
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2. There is limited information on what is occurring in the individual market where
patients receive care.

ORGANIZATION OF THE STUDY
This dissertation is organized into five chapters. In Chapter 1 the background of
disparities in kidney transplantation and issues related to PKT are discussed. The purpose of
the study is to explore the inequities of standard and PKT. Chapter 2 provides a review of
the literature, which includes an analysis of research specifically focused on the differences
between blacks’ and whites’ access to kidney transplantation. The literature review also
includes a review of factors that affect the selection process for PKT.

Chapter 3 describes

the methods used in conducting the analysis, and Chapter 4 presents the results of these
analyses. Chapter 5 concludes with a discussion of the findings and possible next steps
advanced by this work.
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CHAPTER 2. REVIEW OF THE LITERATURE

RACIAL DIFFERENCES IN ACCESS TO KIDNEY TRANSPLANTATION
Racial differences in access to conventional or PKT involve several elements.
Included among the most influential of these are when blacks are diagnosed with chronic
kidney disease, when they are referred to a specialist, and when they are placed on the
transplant waiting list. Each of these junctures in the transplant process reflects racial
differences in access to transplantation, which will be reviewed.
Eggers (1995) went beyond previous works that had examined differences between
black and white transplant populations. Instead of merely examining overall kidney
transplant rates and waiting times to measure access to transplantation, he used three
measures: time from renal failure to transplant, time from renal failure to waiting listing, and
time from waiting list to transplantation.
Three data sets were matched for Eggers’ analysis: (1) The Organ Procurement
Transplant Network (OPTN) wait list and Health Care Financing Administration (HCFA)
data sets and (2) the ESRD Program Management and Medical Information System
(PMMIS). The OPTN wait list data consists of two files, the current active wait list file and
the removals file that contains information on persons no longer on the active list. The wait
list file used in this study contained 26,025 active records and the removals file 76,417
records. The HCFA ESRD PMMIS is a longitudinal file of ESRD patients entitled to
Medicare benefits that is maintained by HCFA’s Bureau of Data Management and Strategy.
The ESRD PMMIS file used in this study was updated through April 1994. This updated file
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contained 582,330 people, the complete count of Medicare ESRD patients ever entitled since
1978.
Three measures of access to transplantation were derived for this analysis by Eggers
(1995). In all three cases, a time-to-event model was used with measure specific censoring.
There were a total of 79,527 persons under 55 years of age who initiated renal replacement
therapy during the years covered by the study. Blacks were most likely to have their renal
failure attributed to hypertension (34.1%), and males comprised the majority of persons in all
racial groups, ranging from 52.8% for Asians to 59.8% for blacks. There was little
difference in the age distribution. Incidence overall was 81 per million population.
Incidence was comparable between Asians and whites; however, compared with whites,
blacks were almost four times as likely to suffer renal failure. Access to transplantation was
inversely related to age, decreasing from 45.7% for persons less than 15 years of age to 8.1%
for persons 45-54 years of age. At one year following renal failure, whites were almost four
times more likely to have received a transplant than blacks. At five years post renal failure,
fewer than one-third of blacks (30.3%) had received a transplant, while well over one-half
(56.7%) of whites had received a transplant.
Black ESRD patients were least likely to get wait listed of all racial groups, with only
17.8% wait listed in the first year of renal failure. Transplantation rates after wait listing
were highest for whites; over one-half were transplanted within one year of wait listing.
However, the ethnic differences narrowed in subsequent years. For example, the black rate
was only 68% as great as the white rate in the first year of wait listing. For those persons still
not transplanted by the end of the second year, the transplantation rate for black patients was
90% as great as that for white patients.
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Race had a significant impact on all three measures of transplant access. Blacks were
only 37% as likely as whites to get a transplant (including living donor). They were only
64% as likely as whites to get on the wait list and only 66% as likely to get a cadaver
transplant after being wait listed. The author concluded that black ESRD patients lagged
behind white patients in transplantation after wait list enrollment. A similar disparity existed
in the primary step of getting on the wait list in the first place. The investigator concluded
that no matter what measure of transplant access was used; blacks with ESRD fare worse
than whites (Eggers, 1995). In addition, wait times following OPTN enrollment increased
more for black patients than for any other racial group between 1988 and 1991.
Young and Gaston (2000) examined the influence of race on renal transplantation and
summarized the effect of multiple interrelated scientific and political factors on the care of
blacks with kidney failure. The major significance of this work was the authors’ descriptive
examination of the current United Network for Organ Sharing (UNOS) algorithm for organ
allocation, which they proposed perpetuates racial disparity (Young & Gaston, 2000).
Specifically, the authors cited the allocation policy that requires ABO blood type as
disadvantaging black candidates. This conclusion was attributed to the longer wait times for
transplantation that were associated with ABO types that occurred more frequently in the
black population (UNOS 1998 Annual Report). The longer wait time is a product of the
relative weight of HLA antigen matching allocated by the UNOS allocation algorithms
(Young & Gaston, 2000). This algorithm awards points to wait listed transplant candidates
based on several factors, including HLA match. When a kidney becomes available, the
candidate with the most points is designated to receive that organ. Because an underlying
assumption is that similarity in HLA antigen matching between donor and recipient
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optimizes outcomes, matching is the predominant variable determining the allocation of
cadaver kidneys (Norman et al., 1995). Therefore the degree of donor recipient match is
heavily weighted in the algorithm. Thus several immunologic factors combined to place
blacks at a disadvantage in regard to the HLA match—with the net result being a preference
for white candidates for transplantation (Young & Gaston, 2000). Beatty, Mori, and Milford
(1995) supported this observation, noting that blacks were only 28% as likely as whites to
find a completely HLA matched donor among 500,000 potential donors. Young and Gaston
(2000) pointed out that on the wait list containing more than 60% blacks, only 1 of 33 fully
matched cadaver kidneys went to a black recipient. They went on to note that, nationally,
14% of all cadaver kidneys were transplanted into fully matched recipients, of whom 90%
were white and only 9% were black. Young and Gaston (2000) concluded that the primary
benefit of the current allocation system is directed toward the predominantly white recipients
with completely matched grafts.
In another examination of racial disparities in access to renal transplantation, Epstein
et al. (2000) focused on whether the declining rate of transplantation in blacks was clinically
appropriate or due to care underuse by blacks or overuse by whites. Specifically, the critical
questions asked were whether blacks were less likely than whites to undergo necessary
surgical procedures, and whether whites were more likely than blacks to undergo surgical
procedures when non-surgical management was indicated.
This unique analysis was conducted by using a literature review and an expert panel
to develop criteria for determining the appropriateness of renal transplantation for patients
with ESRD. The criteria were based on the appropriateness of the presence or absence of
factors constituting absolute or relative contraindications to transplantation. To develop the
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criteria, they used the study conducted by RAND (Park et al., 1986) and described by the
Institute of Medicine (IOM Committee on Clinical Practice Guidelines, 1992).
Data on patients with ESRD were obtained from four regional ESRD networks that
serve geographically diverse areas of Alabama; southern California; Michigan; and the
District of Columbia, Maryland, and Virginia. To obtain a sample of 1,500 patients, the
researchers selected a stratified random sample of blacks and whites from each region. They
compared the demographic and clinical characteristics of patients in an analysis stratified
according to sex as well as race. The t-test was used for continuous variables and the chisquare test for categorical variables. They used two logistic-regression models and a
multivariate logistic-regression model to examine the effect of covariates on appropriateness
ratings.
The results indicated that blacks were less likely than whites to be rated as appropriate
candidates for transplantation according to appropriateness criteria (71 blacks [9.0%] vs. 152
whites [20.9%]). Additionally, blacks were found to be more likely to have had incomplete
evaluations (368 [46.5%] vs. 282 [38.8%], p < 0.001 for the overall chi-square). Among
patients considered to be appropriate candidates for transplantation, blacks were less likely
than whites to be referred for evaluation, (90.1% vs. 98.0%, p = 0.008), to be placed on a
waiting list (71.0% vs. 86.7%, p = 0.007), or to undergo transplantation (16.9 % vs. 52.0%,
p < 0.001). Among patients classified as inappropriate candidates, whites were more likely
than blacks to be referred for evaluation (57.8% vs. 38.4%), to be placed on a waiting list
(30.9% vs. 17.4%), and to undergo transplantation (10.3% vs. 2.2%, p < 0.001 for all three
comparisons).
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Epstein et al. (2000) concluded that racial disparities in rates of renal transplantation
stemmed from differences in clinical characteristics that affected appropriateness as well as
from underuse of transplantation among blacks and overuse among whites. In the opinion of
the authors, reducing racial disparities would require efforts to distinguish their specific
causes and the development of interventions tailored to address them.
The conclusions reached by Epstein et al. (2000) support the earlier conclusions
reached by Alexander and Sehgal (1998), who documented a sequence of potential barriers
along the clinical pathway to renal transplantation. It was the position of the researchers that
intervention at any single point is unlikely to eliminate racial disparities. Their findings that
blacks were less likely to be appropriate candidates for transplantation than were whites
suggest that even if blacks and whites had equal access to renal transplantation, their rates of
referral, placement on a waiting list, rate of transplantation or their cost break-even point
might not be the same.
Epstein et al. (2000) readily acknowledged several limitations of their study. First, the
number of patients in the underuse group considered to be appropriate candidates for
transplantation was small, possibly allowing unstudied factors to bias the results. Second,
appropriateness ratings varied among expert panels, and the number of persons in overuse
and underuse categories would, therefore, likely vary according to the particular panel used.
However, the researchers propose that this variation would not affect racial differences in
ratings. Third, the study sample was restricted to persons between the ages of 18 and 54
years. Whereas a substantial proportion of patients receiving dialysis for the first time were
55 or older, there was also a substantial decline in rates of transplantation among older
patients. Finally, the study examined a condition for which almost all patients in the United
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States have insurance coverage through Medicare and are in close contact with the medical
care system through dialysis and transplantation two factors that would be expected to reduce
racial disparities in care.
Foster et al. (2002) reviewed renal transplantation in blacks over a ten year period.
Their objective was to evaluate the strategies instituted by a transplant center to decrease
time on the waiting list and increase the rate of transplantation for blacks. The intervention
consisted of a formal education program oriented toward blacks concerning benefits of living
organ donation.
During the study period, from March 1990 to November 2001, data were obtained
from 2,167 renal transplants; 944 were blacks (663 primary cadaver renal transplants and 253
primary living donor renal transplants). Outcome measures of this historical cohort study
found median waiting time for cadaver renal transplant for whites was 391 days compared
with 647 days for blacks. Foster et al. (2002) concluded that programs specifically oriented
to improving volunteerism in blacks lead to a marked improvement in overall waiting time
and in rates of living donation in the patient group. The median waiting times for cadaver
renal transplantation were also significantly shorter. These programs markedly improved
ESRD care for blacks by cutting in half the overall waiting time while still achieving
comparable graft and patient survival rates. It should be noted that the results of this study
were only qualitative, non-statistical comparisons that used a methodology for calculating
waiting time that was different than that used by UNOS, which takes into account death on
the waiting list. Additionally, some transplant programs do not register living donors with
UNOS, possibly inflating overall waiting time.
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A racial difference in access to the kidney transplant waiting list has also been found
in pediatric patients. Furth et al. (2000) sought to determine whether the increased time to
transplantation for black pediatric patients was attributable not only to a shortage of suitable
pediatric donor organs but also to racial differences. They conducted a national longitudinal
cohort study of U.S.-Medicare-eligible pediatric ESRD patients. Study subjects included
children and adolescents < 19 years old at the time of their first dialysis between 1988 and
1993, who were followed though 1996. Patients who received living donor renal transplants
were excluded from the study. The primary outcome measures were the time from first
dialysis until activation on the kidney transplant waiting list and the likelihood of activation
on the waiting list for black compared with white pediatric patients.
Furth et al. (2000) found that for the 2,162 white (60.7%) and 1,122 black (31.5%)
patients studied using survival analysis, blacks were less likely to be wait listed at any given
time in follow up. In multivariable analysis even after controlling for patient age, gender,
socioeconomic status, geographic region, incident year of renal failure, and cause of ESRD
blacks were 12% less likely to be wait listed than whites at any point in time (relative hazard:
0.88; 95% confidence interval; 0.79-0.97).
Among black patients, 28.6 patients were wait listed per 100 person-years of follow
up, compared with 33.9 for whites. Two hundred fifty-two patients (7.7%) were activated on
the waiting list before their first dialysis; 76% of these patients were white. The cumulative
incidence of patient wait listing according to race is shown in Fig. 2-1. Kaplan-Meier
analyses demonstrated that at any point in time black patients were less likely than were
white patients to be activated on the kidney transplant waiting list (P = .007, log-rank test).
The disparity was present early on and remained relatively constant over time.
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Figure 2-1. Cumulative incidence of wait listing for black and white pediatric patients
after first dialysis for ESRD.
Source: Furth S.L., et al. Racial differences in access to the Kidney Transplant Waiting List
for Children and Adolescents with ESRD. Transplantation, 2000; S237. Reprinted with
permission.

To assess the independent effect of race on time from first dialysis until activation on
the kidney transplant waiting list, Fruth et al. (2000) performed a Cox proportional hazards
analysis and found that even after controlling for important confounders identified in the
Kaplan-Meier analyses (including patient age, gender, socioeconomic status, assigned cause
of ESRD, geographic region, and incident year of dialysis), blacks were still 12% less likely
than whites to be activated on the kidney transplant waiting list (relative hazard: 0.88; 95%
confidence interval [CI]: 0.79, 0.97).
Several limitations of the Fruth et al. (2000) study deserve mention. Any errors in the
recorded dates of first dialysis and first wait listing would be expected to be random and not
associated with patient race. This random misclassification would tend to minimize rather
than exaggerate the racial differences in time from first dialysis for ESRD to activation on the
wait list that the researchers saw.
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Fruth et al. (2002) concluded that racial disparities in access to the renal transplant
waiting list existed when black children experienced delayed access to this therapy.
Whether these disparities were attributable to differences in time of presentation to
nephrologists, physician bias in identification of transplant candidates, or patient preferences
warrant further study. This is the first known report that documents the racial differences in
access to renal transplantation extended beyond the adult population to include children.
Young and Gaston (2002) reviewed published reports that examined the connection
between race and the incidence of chronic renal failure, access to optimal therapy, and
outcomes of renal transplantation. This research underscored the point that blacks with
ESRD are at the epicenter of continued debate about access to transplantation of renal
allograft. The literature reviewed in this area pointed out that the impact of race on delivery
of care in ESRD remains controversial. According to the authors, it was the exaggerated
incidence of kidney failure among blacks, along with the under-representation of those
patients receiving cadaver renal allograft that continues to fuel the controversy. Young and
Gaston’s brief review was intended to summarize the impact of multiple interrelated
scientific and political variables on blacks with kidney failure. Summarizing Young and
Gaston’s 2002 review, the incidence of ESRD in blacks was four times greater than that in
whites, but blacks remained less likely than whites to be referred for or to undergo renal
transplantation. Blacks remained disadvantaged in both access and outcomes. The authors
concluded that further evaluation of underlying causes and development of specific remedies
are warranted.
Ayanian et al. (2004) conducted research on physicians’ beliefs about racial
differences in referral for renal transplantation. According to Ayanian et al. (2004) a better
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understanding of physicians’ views about racial differences in access to transplantation might
help reduce disparities in care. Their study surveyed 278 nephrologists in four U.S. regions
regarding quality of life and survival for blacks and whites undergoing renal transplantation
and also the reasons for racial differences in access to transplantation. They also surveyed
606 of their own patients about their care. The physicians were less likely to believe that
transplantation improved survival for blacks than whites (69% versus 81%; P = 0.001), but
were likely to believe it improved quality of life (84% versus 86%). Factors commonly cited
by physicians as important reasons why blacks are less likely than whites to be evaluated for
transplantation included patients’ preferences (66%), availability of living donors (66%),
failure to complete evaluations (53%), and comorbid illnesses (52%). Fewer physicians
perceived patient-physician communication and trust (38%) or physician bias (12%) as
important reasons. Black patients were less likely than white patients to report receiving
some or a lot of information about transplantation (55% versus 74%; P = 0.006) when their
physicians did not view patient-physician communication and trust as an important reason for
racial differences in care. Aryanian et al. (2004) concluded that nephrologist’ views about
the benefits of renal transplantation and reasons for racial differences in access might have
affected how they present this treatment option to black and white patients.

PREEMPTIVE KIDNEY TRANSPLANTATION
Until the mid-1980s, the general feeling was that PKT was associated with inferior
results compared with post dialysis transplantation (Jacobs et al., 1977) but the literature
remained sparse. However, the later published clinical experiences of PKT in adults
(Migliori et al., 1987; Tegzess et al. 1987; Katz et al., 1991) suggested that the outcome
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might not be different from that following conventional cadaver transplantation. Migliori et
al. (1987) reported a case control study of 132 preemptive transplants performed between
1968 and 1984. Those from cadaver donors (36 transplants) had relatively poor outcomes, a
finding which was attributed to the high number of diabetics in this group. Katz et al. (1991)
reported 85 consecutive preemptive transplants (47 and 38 from living and cadaver donors,
respectively) between 1981 and 1988. Patient and graft survival rates were not different
from those of the controls for the group as a whole or for living and cadaver donors analyzed
separately. However, according to this investigation the preemptively transplanted group
experienced significantly more rejection episodes attributed to noncompliance.
With the work of Tegzess (1987), Migliori (1987), and Katz (1991) leaving questions
about PKT unanswered, Roake et al. (1996) conducted an analysis to compare the results of
conventional cadaver renal transplantation with PKT at the Oxford Transplant Center. They
sought to establish whether or not PKT could be justified on the basis of clinical outcome.
For the purposes of their analysis Roake et al. (1996) defined PKT as the first transplantation
before the need for chronic dialysis, including patients in whom the first dialysis was no
more than 48 hours before transplantation. The analysis was a retrospective case-control
study, subject to the risk of bias inherent in this type of analysis. The controls were selected,
as far as possible, to be well matched to the PKT group, but some significant differences
were present with respect to several variables that could have potential impact on graft
survival. Furthermore, as a direct result of the study design, the controls developed ESRD
failure at an earlier age than the PKT group, possibly as a consequence of more aggressive
primary disease and this difference may have influenced patient survival.
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Patients who underwent PKT between June 1976 and December 1994 at the Oxford
Transplant Center were compared with matched controls of first cadaver transplant recipients
who were dialysis dependent when transplanted. The 116 patients in the PKT cohort were
well matched to the control group with respect to sex, and blood group, and HLA match,
degree of sensitization, donor age, immunosuppression, and year of transplantation. Both
patient and graft survival were significantly better in the PKT group Differences in graft
survival did not appear to be explained completely by better patient survival. Among
surviving grafts there were no significant differences in graft function, as assessed by 1, 2,
and 3 year plasma creatinine levels. Roake et al. (1996) concluded that PKT appeared to be
safe and might even be associated with superior graft survival when compared with
conventional transplantation. In a cautionary admonishment, they stated that early inclusion
on a transplant waiting list with a view to PKT could be justified with respect to the clinical
outcomes, but the financial costs and implications for the utilization of cadaver donor
kidneys must also be considered.
By 2000, the research on PKT had shifted to an argument against waiting until
dialysis. Papalois et al. (2000) acknowledged that PKT had not been favored in some centers
because of concern about possible increased noncompliance and allegedly inferior long term
results and analyzed their experiences to determine whether such concerns were justified.
This research was an extension of previously reported research (Migliori et al., 1987) that
found no significant disadvantages with PKT. In the follow up study the purpose of the
analysis was to assess the potential benefits of PKT for long term patient and graft survival
rates as well as for post transplantation quality of life. Papalois et al. (2000) reviewed their
centers’ experience with 1,849 primary adult kidney transplants from January 1, 1984 to June
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30, 1998. The analysis included 385 PKT and 1,464 non- PKT. The results were subdivided
by donor source: cadaver and living donor. The PKT patients tended to be younger, but
otherwise the two groups were similar.
The 5-year actuarial patient survival rate was superior for PKT patients regardless of
donor source (96.6% vs. 76.6%, p = 0.001 for cadaver transplants and 93.3% vs. 89.5%, p =
0.02 for living donor transplants). The results were significantly higher for PKT recipients
compared with recipients undergoing dialysis for < 1, 1-2, and > 2 years pre-transplant for
both cadaver and living donor transplants. The conclusions reached were that PKT patients
did not seem to have higher rates of noncompliance than those receiving dialysis. The results
also seemed to indicate superior outcomes for PKT patients than for those who underwent
some period of dialysis, supporting the contention that renal failure patients should, if
possible, undergo transplantation before chronic dialysis. The quality of life for the PKT
patients and those who received dialysis did not differ, nor did the post transplantation
employment status. The results clearly refuted the argument that PKT decreased the quality
of life or disabled PKT recipients. The superior outcome associated with PKT raised the
issue of optimal timing for transplantation.
Beginning where Papalois et al. (2000) left off, Kasiske et al. (2002) further examined
whether PKT actually was beneficial and, if so, who benefited. Using UNOS and USRDS
data, they examined the characteristics of patients who received PKT. They also examined
whether the effects on outcomes were similar in both cadaver and living donor transplant
recipients, and whether these effects were independent of recipient age, year of
transplantation, and other factors. The analysis retrospectively examined 38,836 first kidneyonly transplants between 1995 and 1998. Surprisingly, 39% of the PKT were from cadaver
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donors; however, it should be noted that the proportions of cadaver donor transplants that
were PKT changed very little—from 7.3% in 1995 to 7.7% in 1998.
In the study of Kasiske et al. (2002), the researchers found that there was a greater
likelihood of PKT among patients who (1) had a living donor; (2) were younger than 18
years old; (3) were white; (4) were not Hispanic; (5) were better educated; (6) were working
full time; (7) had a primary payer other than Medicare; and (8) had 0 to 1 HLA-antigen
mismatches. PKT was relatively more likely among children in this study, given that every
effort is made to transplant children as soon as possible to improve their growth and
development. Patients who received PKT were more likely to be employed both before and
after transplantation than patients who did not receive PKT. Race and education were each
independently associated with preemptive transplantation. One of the strongest correlates to
preemptive transplantation was the primary source of payment. Patients who had Medicare
as the primary payer were much less likely to receive preemptive transplantation. As the
researchers pointed out, having Medicare as the primary payer could have been a surrogate
for other factors, such as ethnicity. They concluded that the need to rely on Medicare itself
may have discouraged PKT.
In conclusion, the results of this study (Kasiske et al. 2002) strongly suggested that
PKT is beneficial. The reason for this additional, long term benefit associated with PKT
remained unclear, but the researchers hypotheses that it could be related to the avoidance of
one or more comorbidities, e.g., cardiovascular disease, that may have otherwise developed
during treatment with maintenance dialysis.
PKT is associated with allograft survival advantage and is promoted in part because
of this association. Because the basis for the allograft survival advantage in preemptive
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recipients remains unclear, Gill et al. (2004) further explored this relationship by focusing on
the possibility that the advantages seen in PKT patients were due to a lead time bias derived
from the earlier transplantation of patients with preserved native kidney function. Other
possibilities included less rapid loss of kidney function after transplantation, or the possibility
that the advantage could be explained simply by longer patient survival of PKT patients.
In attempting to determine why PKT recipients had an allograft survival advantage,
Gill et al.(2004) research focused their research on a comparison of the glomerular filtration
rate (GFR) six months after transplantation and the subsequent rate of loss of kidney function
as defined by the annualized change in GFR (mL/min/1.732/year) in 5,966 preemptive and
34,997 non-preemptive recipients. Linear regression methods were applied to serial GFR
estimates after transplantation to determine the annualized change in GFR. Multiple
regression was used to determine the independent effect of preemptive transplantation upon
the annualized change in GFR. The results showed that the mean GFR 6 months after
transplantation was similar among PKT (49.5 ± 15.7 mL/min/1.73m2) and non-preemptive
(49.2 ± 14.7 mL/min/1.73m2) recipients (P = 0.37). In multivariate analysis, preemptive
recipients had a slower decline in GFR (0.28 mL/min/year/1.73m2; 95% confidence interval
0.11, 0.46; P = 0.002). However, this difference was of modest clinical significance and
would not explain the allograft survival advantage of preemptive transplantation. Having
found no meaningful significance, the researchers concluded that neither the preservation of
native kidney function nor differences in the rate of loss of kidney function explained the
superior allograft survival of preemptive recipients. They concluded with the hypothesis that
the apparent allograft survival advantage of PKT is the result of improved patient survival
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resulting from patient selection or the reduced severity of comorbid disease associated with
avoidance of dialysis.
The Gill et al. (2004) analysis found that PKT was more common among non-blacks.
Other reports in the literature also indicate that whites are more likely than blacks to have a
living donor. In addition, PKT recipients were found to be younger, female, and non-HLA
mismatched patients, and patients with polycystic disease.
Kasiske et al. (1998) conducted an analysis specifically focused on race and
socioeconomic factors influencing early placement on the kidney transplant waiting list.
This cohort study investigated whether there were inequities in the current system for listing
patients for cadaver renal transplantation, using bivariate and multivariable analyses to
identify factors associated with early registration before initiation of dialysis. While this
analysis did not focus on PKT specifically, the examination of waiting times is relevant in
creating a perspective for other literature to be reviewed and the analysis conducted in the
current research that looked at the differences in PKT rates between blacks and whites.
Kasiske et al. (1998) noted that UNOS has established a system for allocating kidneys
for cadaver transplantation that is designed to be both equitable and efficient. The UNOS
point system for allocating kidneys awards points for waiting time, so that individuals who
have waited longer are more likely to receive a kidney, all other factors being equal (UNOS
Policy 3.5: Allocation of Cadaver Kidneys, 1997). Based on this policy, it is clear that
physicians and patients want registration to take place as soon as possible, to begin accruing
waiting time. It is certainly an advantage to register for transplantation before initiating
maintenance dialysis. According to the authors, registering before dialysis theoretically may
allow patients to receive a transplant before initiating dialysis, and thereby obviating the need
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for permanent dialysis access. However, given the long waiting time, PKT is usually not
possible with a cadaver kidney. Although the research perspective articulated by Kasiske et
al. (1998) was that registering before transplantation usually offers no practical advantage
other than waiting time accrual, Kasiske et al. (1998) used registration before maintenance
dialysis initiation as an indicator of early listing for cadaver renal transplantation. Because
listing before dialysis may be advantageous with regard to waiting time accrual, the
investigators sought to determine whether there were differences in patients who did or did
not register before dialysis. Major differences in patients who registered before versus those
who registered after initiating dialysis could indicate potential inequities in the allocation
system, and/or in access to health care in general.
The analysis of Kasiske et al. (1998) included all patients who registered with UNOS
on the OPTN kidney and kidney pancreas waiting list between April 1, 1994, and June 30,
1996 (n = 41,596) from all 238 UNOS renal transplant centers. The information in the
database was collected using the UNOS Transplant Candidate Registration Form. The
research included the following variables: gender, age, history of previous kidney transplant,
highest education level achieved, ethnicity, employment status, projected payment source,
registration at a high volume center, diabetes/insulin dependent, kidney versus kidney
pancreas registration, functional status at registration, and the year of listing (1994, 1995,
1996). The statistical analysis included both bivariate and multivariable analyses (Kasiske et
al., 1998).
In the univariate analysis, of all the registrations—41,596 (18.4%)—were not yet on
dialysis. A number of characteristics were different between those not yet on dialysis and
those on dialysis at the time of listing. Although 59.3% of all registrations were male, of
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those not yet on dialysis, only 57.7% were male. Those not yet on dialysis were younger
and more likely to have had a prior transplant. They were better educated and were more
often white. They were more likely to have private insurance, listed at a high volume center,
to be diabetic. The multivariable analysis revealed that for all registrations, the odds of being
listed before undergoing maintenance dialysis were 15% greater for females compared with
males. Individuals with a prior transplant were 80% more likely to be listed before dialysis.
The more years of schooling a patient had, the more likely the patient was to have been listed
before dialysis. Blacks were 47% as likely as whites to be listed before dialysis. Individuals
employed full time were more likely to be listed before dialysis compared with those who
were working less than full time. Compared with patients with other payment sources, those
whose primary source of payment was Medicare were only 34% as likely, whereas those
with private insurance were 21% more likely to be listed before dialysis. Of special note was
that 0 to 8 years of education correlated with a greater likelihood of being listed before
dialysis, compared with a reduced likelihood when the larger population of patients was
analyzed.
Kasiske et al. (1998) assumed that pre-dialysis at the time of listing could be used as
an indicator of placement on the waiting list earlier in the course of renal disease than
registration of patients who were already on dialysis. They also assumed that patients were
placed on dialysis because of signs, symptoms, and laboratory indicators of ESRD, and not
for other, non-medical reasons. They concluded that it is advantageous for patients to be
placed on the waiting list as soon as possible, because waiting time adds points to the total
UNOS point score and thereby helps determine how long a patient may wait for a kidney.
The greater the number of points the more likely the patient will be transplanted soon.
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Listing patients as soon as possible is also advantageous to centers that may wish to
transplant as may patients as soon as possible. As a matter of fact in the Kasiske et al. (1998)
study, a logistic regression model testing for center effect did indeed find that some centers
listed patients sooner (before dialysis) more often than other centers.
Kasiske et al. (1998) found that race and socioeconomic factors influenced early
listing. Patients who were younger, better educated, white, and working full time, and who
had better insurance coverage were more often listed before dialysis (compared with patients
who were older, less well educated, or a racial or ethnic minority working less than full time,
and who had less insurance coverage). Kasiske et al. (1998) concluded that early listing can
now be added to a growing number of steps along the road to renal transplantation that seem
to be influenced by ethnicity, gender, and socioeconomic factors. Identification of potential
candidates for renal transplantation is influenced by ethnicity, gender, employment status,
and education level (Soucie et al., 1992). Furthermore research of Soucie et al. (1992)
supports the proposition that even after having been placed on the cadaver transplant wait list
the, ethnicity, age, and gender of transplant candidates have been shown to affect the waiting
time.
Several recent studies reflected in this literature review have confirmed the survival
advantage for renal transplant patients over those waiting on a transplant receiving
maintenance dialysis. Meier-Kriesche et al. (2000) furthered this work by investigating the
hypothesis that longer waiting times are more deleterious than shorter waiting times, that is,
their objective was to detect a “dose effect” for waiting time. The issue of waiting times is
addressed herein due to the direct impact this factor has on the decision for PKT.
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Meier-Kriesche et al. (2000) included 73,103 primary adult renal transplants
registered at the USRDS registry from 1988 to 1997 with the primary end points of death
with functioning graft and death censored graft failure. All Cox proportional hazard models
were corrected for donor and recipient demographics and other factors known to affect
outcome after kidney transplantation. The study sample consisted of patients who underwent
solitary primary (multiorgan and secondary transplants were excluded from the analysis)
renal transplantation. Waiting time on dialysis was calculated from the start of maintenance
dialysis treatment to transplant date. The impact of waiting time on dialysis prior to
transplantation on the primary end points was analyzed both as a continuous variable and as a
categorical variable. The results showed increasing waiting time on dialysis was a significant
risk factor for death-censored graft loss after renal transplantation (P < 0.001). Being on
dialysis for up to 6 months prior to transplantation conferred a 17% increased risk for deathcensored graft loss as compared with PKT when adjusted for all factors considered in this
analysis. Dialysis treatment for 6 to 12, 12 to 24, and 24 to 36 months prior to renal
transplantation conferred a 37%, 55%, and 68% higher risk for death-censored graft loss,
respectively. Beyond 36 months of dialysis, there remained a significantly increased risk of
death censored graft loss as opposed to PKT (P < 0.001); however the relative increase
beyond 36 months from 68% to 70% to 74% was small and not statistically significant.
Other significant risk factors for death-censored graft loss were black recipient (P < 0.001),
black donor (P < 0.001), higher donor age (P < 0.001), higher HLA mismatch (P < 0.001)
and diabetes as the cause of ESRD (P < 0.001). When adjusting for all factors being
considered in this analysis increasing waiting time on dialysis was also a significant risk
factor for patient death with a functioning graft after renal transplantation (P < 0.001).
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Meier-Kriesche et al. (2000) demonstrated that waiting time on dialysis is a strong,
independent risk factor for decreased patient survival as well as decreased death-censored
graft survival following renal transplantation. This effect was independent of all other
factors in the model (including recipient age, ethnicity, original disease, and donor
characteristics) and likely reflects a true negative effect of waiting time on dialysis. This
effect appeared to be “dose dependent” the longer the waiting period the greater the risk for
either of these negative outcomes. Meier-Kriesche et al.(2000) provided strong support for
the hypothesis that patients who reach ESRD should receive a renal transplant as early as
possible in order to enhance their chances of long term survival.
Failure to complete the medical evaluation for renal transplantation may impede
access to transplantation and preclude the possibility of PKT. Research conducted by Weng
et al. (2003) sought to (1) characterize completion rates of the transplantation medical
evaluation and (2) determine factors associated with completion of the evaluation. The
research was conducted based on the hypothesis that patients not yet on dialysis therapy
complete the evaluation process more quickly than patients receiving dialysis. Between
September 2002 and September 2003, patients evaluated for renal transplantation at the
Hospital of the University of Pennsylvania (Philadelphia, PA) were enrolled in an
observational, prospective, cohort study. Of 356 patients who presented for evaluation, 175
patients were included in this analysis. The electronic medical record (EMR) was examined
after all patients had the opportunity to accrue a minimum of 6 months of follow-up since
their initial evaluation. The transplantation evaluation was considered complete if the patient
was placed on the UNOS waiting list for a deceased donor renal transplant or the patient
received a renal transplant, whichever occurred first. As standard practice for this transplant
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center, all patients who successfully completed the medical evaluation were listed for a
deceased donor renal transplant. Therefore, the transplant center staff considered the listing
for deceased donor transplantation to signify successful completion of the pre-transplantation
workup.
Weng et al. (2003) examined the association between dialysis status at the initial
transplantation evaluation visit and time until completion of the medical evaluation. A Cox
proportional hazard model was fit to examine the relationship between baseline covariates,
particularly dialysis status, and time to completion of the transplantation evaluation. Of the
175 study participants, a slight majority (54.3%) were receiving maintenance dialysis at the
time of initial transplantation evaluation. Patients receiving dialysis were more likely to be
black, lack a college education, report disability or unemployment, have a lower annual
household income, and list Medicare as their medical insurance compared with patients not
yet on dialysis therapy. In an unadjusted Cox analysis, dialysis status at the time of the initial
transplantation was associated with a slower rate of completion of the evaluation. The
association between dialysis status at the time of the initial transplantation evaluation and
time to completion of the transplantation evaluation did not persist in the multivariable model
(adjusted HR, 0.92; 95% CI, 0.60 to 1.42; P = 0.72). After adjusting for other factors, black
ethnicity remained associated with decreased rates of completion of the transplantation
evaluation (adjusted HR, 0.63; 95% CI, 0.40 to 1.00; P = 0.05).
Weng et al. (2003) had a novel prospective recruitment of all patients who appeared
for transplantation evaluation, regardless of patient dialysis status or availability of living
donors. Previous investigations of the transplantation process were restricted to patients
either receiving maintenance dialysis (Alexander et al., 1998; Ayanian et al., 1999) or
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seeking deceased donor transplants (Kasiske et al., 1998; Alexander et al., 2002). The broad,
inclusive criteria of Weng et al. (2005) permitted examination of the impacts of dialysis
status and type of transplant donor, two factors that influence patient and allograft survival
on completion of the transplantation evaluation. These factors have not been previously
studied extensively as determinants of access to transplantation. Another novel feature of the
study by Weng and coworkers (2005) is its focus on the medical evaluation for renal
transplantation process.
Weng et al. (2005) admitted that the study had important limitations including, but
not limited to, it’s possibly being underpowered to detect differences in the completion of the
transplantation evaluation by dialysis and non-dialysis patients. Second, because the study
reflected the referral population of a single transplant center and the practices of the center’s
transplant team, these results were not necessarily generalizable to other transplant centers.
Third, although they collected information on many potential confounders, residual
confounding remained a possibility. In particular, they had limited ability to adjust for
comorbidity and case-mix severity. Specifically, greater comorbidity among blacks could
have contributed to the slow rate at which blacks completed the transplantation evaluation.
To minimize this confounding, they recorded the number and type of tests and evaluations
requested by the transplant team. After adjustment for these requested tests and evaluation,
blacks still remained associated with decreased rates of completion of the transplant
evaluation.
In summary, Weng et al. (2005) concluded that the completion of the medical
evaluation for transplantation was unrelated to dialysis status. The process was slower in
blacks than whites and was associated with various socioeconomic factors. Rapid
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completion of the transplantation evaluation process would benefit all potential candidates
for renal transplantation, irrespective of dialysis status or ethnicity. Additional studies are
needed to help determine the root causes of variations in completion of the medical
evaluation and devise appropriate interventions (Powe & Boulware, 2002). Interventions
that expedite the medical evaluation while retaining its thoroughness may improve patient
access to renal transplantation, increase rates of PKT, and possibly lead to better outcomes.
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CHAPTER 3. METHODOLOGY

DATA OVERVIEW
The current research is a historical cohort study of all patients who experienced
ESRD and/or received a cadaver kidney transplants between January 1, 2000 and December
31, 2003. The patients were identified using data acquired from the standard analytic files
(SAF) of the USRDS. Patients from the dataset were included in the study if they (1) were
designated by CMS as having ESRD, (2) had their first ESRD service and/or underwent a
cadaver kidney transplant between January 1, 2000 and December 31, 2003, (2) were either
black or white, and (3) were not < 19 years old at the time of transplant. Patients were
excluded if they had more than one kidney transplant, or multi-organ transplants were
obtained or if their transplants were obtained from living donors.
The data sources for this study were obtained from the 2000-2004 United States
Renal Data System Database (USRDS) System. The main objective of the USRDS database
is to use all relevant ESRD data to create an integrated and consistent database system for
outcomes research. The database includes ESRD patient demographic and diagnosis data,
biochemical values, dialysis claims, and information on treatment history, hospitalization
events, and physician/supplier services.
The data used by the USRDS originates from Center for Medicare Services (CMS),
United Network for Organ Sharing (UNOS), the Centers for Disease Control (CDC), the End
Stage Renal Disease (ESRD) Networks, and the USRDS special studies section. The major
source of ESRD patient information for the USRDS is the CMS Renal Beneficiary and
Utilization System (REBUS), which was adopted in 1995 as the On-Line Transaction
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Processing (OLTP) system from its predecessor, the Program Management and Medical
Information System (PMMIS) database. The PMMIS/REBUS database contains
demographic, diagnosis, and treatment history information for all Medicare beneficiaries
with ESRD.
Data for input into the database that was utilized for this analysis was derived from
the following sources that are summarized in the USRDS Researcher’s Guide (2005). A
quoted description of each from the Guide follows:
•

CMS Medical Evidence Form (CMS-2728)
The CMS Medical Evidence Form is completed by the renal provider
for each new ESRD patient, and is sent to CMS through the ESRD Networks.
It serves to establish Medicare eligibility for individuals who previously were
not Medicare beneficiaries, reclassify previously eligible Medicare
beneficiaries as ESRD patients, and provide demographic and diagnostic
information on all new ESRD patients regardless of Medicare entitlement.
Before 1995, dialysis units and transplant centers were required to file the
Medical Evidence Report only for Medicare eligible patients. With the
adoption of the newly revised form in 1995, however, providers are now
required to complete the form for all new ESRD patients regardless of
Medicare eligibility status. The revised form also contains new fields for
comorbid conditions, employment status, race (the categories have been
expanded), ethnicity, and biochemical data at the start of ESRD (USRDS
Researcher’s Guide, 2005; 21).
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•

CMS ESRD Death Notification Form (CMS-2746)
Like the Medical Evidence Report, the Death Notification Form is data
rich, and its completion by renal providers is enforced by CMS. Providers
usually have 45 days to report ESRD death events to their respective ESRD
Networks, providing information about the place, time, and cause of death.
Data are thus available to the USRDS Coordinating Center to conduct
research on cause-specific mortality outcomes (USRDS Researcher’s Guide,
2005; 21).

•

CMS Medicare Enrollment Database (EDB)
The CMS Enrollment Database is the designated repository of all
Medicare beneficiary enrollment and entitlement data, including current and
historical information on beneficiary residence, Medicare as Secondary Payer
(MSP) status, and Health Insurance Claim/Beneficiary Identification Code
(HIC/BIC) cross-referencing (USRDS Researcher’s Guide, 2005; 21).

•

CMS Paid Claims Records
Inpatient transplant and outpatient dialysis claims records are
sometimes used to identify new ESRD patients for whom no Medical
Evidence Report has been filed. These patients, who are most likely to be nonMedicare patients or beneficiaries who develop ESRD while already on
Medicare because of old age or disability, will eventually be entered into the
PMMIS/REBUS database-and hence the USRDS-database through the claims
records. For patients without Medical Evidence records, these claims are the
only reliable information from which to determine first service dates for
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ESRD. These paid claims records, however, are only a supplement to-not a
replacement of-other sources of information on incidence and prevalence
(USRDS Researcher’s Guide, 2006; 21-22).
•

UNOS Transplant Database
CMS began collecting data on all Medicare kidney transplants in the
early 1980s. In 1988, UNOS was created to provide a national system for
allocating donor organs and to maintain a centralized data depository on organ
transplantation. UNOS also began collecting data on all transplants.
Subsequently, these two collection efforts were consolidated in 1994, and
UNOS became the sole source on transplant donors and recipients. The CMS
and UNOS transplant data files overlap for 1988–1993, and some patients
with Medical Evidence Reports indicating transplant as the initial modality are
not included in either file. To resolve the conflicts among these three sources,
the USRDS has adopted the following procedure: Prior to 1988 all transplant
events found in CMS PMMIS/ REBUS Transplant files are used. After 1994,
all transplant events found in the UNOS files are used. Between 1988 and
1993, all transplant events found in the UNOS files are used while additional
transplant events are taken from the CMS PMMIS/REBUS Transplant file
only if they occur at least 30 days (either side) of a previously accepted
transplant event. Additionally, transplant events associated with the reported
incident transplant patients from the Medical Evidence Report (CMS-2728)
are taken if they also occur at least 30 days (either side) of a previously
accepted transplant event. The transplant events found in the Transplant file
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of the USRDS SAF Core CD are thus all unique events derived from the
UNOS, CMS PMMIS/REBUS Transplant, and Medical Evidence record files
(USRDS Researcher’s Guide, 2005; 21).
•

CMS ESRD Standard Analytical Files (SAFs)
CMS SAFs contain data from final action claims, submitted by
Medicare beneficiaries, in which all adjustments have been resolved. For Part
A institutional claims, the USRDS uses the following 100% SAF claims:
Inpatient
Outpatient
Skilled nursing facility (SNF)
Home health agency (HHA)
Hospice
For Part-B physician/supplier 100% SAF claims:
Physician/supplier
Durable medical equipment (DME)
CMS SAFs are updated each quarter through June of the next year, when the annual
files are finalized. Datasets for the current year are created six months into the year
and updated quarterly until finalized at 18 months, after which files are frozen and
will not include late arriving claims. Annual files are thus approximately 98%
complete. The USRDS 2005 ADR includes all claims up to December 31, 2003.
Patient-specific demographic and diagnosis information, however, includes data as
recent as October 2004 (USRDS Researcher’s Guide, 2005; 22).
The structure of the USRDS database is presented in Fig. 3-1.
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Figure 3-1. Structure of the USRDS database.
Source: United States Renal Data System Researcher’s Guide to the USRDS Database.
National Institutes of Health, National Institute of Diabetes and Digestive and Kidney
Diseases, Bethesda, MD, 2005. Required notice: “The data reported here [i.e., in this
dissertation] have been supplied by the United States Renal Data System (USRDS). The
interpretation and reporting of these data are the responsibility of the author(s) and in no way
should be seen as an official policy or interpretation of the U.S. government.”
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PROTECTION OF HUMAN SUBJECTS
This study is a secondary data analysis of the USRDS database. Prior to obtaining
any data from USRDS/CMS, approval from Thee University of Tennessee Health Science
Center Institutional Review Board (IRB) was obtained (see Appendix A).

STATISTICAL ANALYSIS
The conceptual framework that guided the statistical analyses is depicted in Fig. 3-2.
This framework begins with the race phenomenon being examined in the context of PKT. In
outlining the knowledge state of ESRD the framework identifies the components, causes of
ESRD and demographic characteristics that may play a part in the diagnosis of ESRD. The
diagnosis of ESRD leads to a referral to a nephrologists, which is the empirical phase of this
research under examination and the theoretical fork in the road that leads either to a PKT or
dialysis and/or placement on the transplant waiting list. The framework identifies the
pathway (depending on whether the patient receives a PKT or not) to whether the patient
survives and or dies.

BLACK
or
WHITE

CAUSE OF ESRD
-Hypertension
-Diabetes
-Glomerulonephritis

REFERRAL TO A
NEPHROLOGIST

DIAGNOSIS OF
ESRD

PLACEMENT ON
TRANSPLANT
WAITING LIST

-Age
-Sex
-Comorbidity
-Employment
-Insurance

LIVED

TIME ON WAITING
LIST

Figure 3-2. Conceptual framework.
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PKT
Vs
Non-PKT

DIED

Separate analyses were carried out for recipients of cadaver PKT and cadaver
conventional kidney transplants grouped by patient’s race. I first examined associations
between patient characteristics listed in Fig. 3-2 and PKT or conventional kidney transplant,
one variable at a time, assessing statistical significance with a  test (categorical data) or t
test (continuous data). A multivariate, logistic regression analysis was used to examine the
relative influence of the variables. This analysis was designed to assess which of the patient
characteristics were independently associated with PKT and conventional kidney transplant.
The effect of race on PKT and conventional kidney transplant was also examined, for
graft and patient survival using the Kaplan-Meier method with a log-rank test for statistical
significance. All analysis was carried out using the statistical software package SAS version
9.1.4 (SAS Institute, Inc., Cary, NC). All results were considered statistically significant if P
< 0.05.

KEY CONCEPTS IN ESRD

Who Is an ESRD Patient?
An ESRD patient is one who has developed chronic renal failure and requires kidney
replacement treatment, dialysis or transplant to sustain life. This is not to be confused with
acute renal failure, in which the patient is expected to recover renal function after several
weeks or months. Those patients who experience acute renal failure and are on dialysis for
days or weeks, but who subsequently recover kidney function, are, as much as possible,
excluded from the ESRD database. A person is identified as having ESRD when a physician
certifies the disease on a medical evidence form (CMS 2728), or when there is other evidence
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that the person has received chronic dialysis or a kidney transplant. The medical evidence
form is completed by renal a renal provider, not only to register the patients in the CMS
ESRD database, but also to apply for their Medicare eligibility if they have not previously
been eligible. Patients who die soon after kidney failure without receiving dialysis treatment
are occasionally missed (USRDS Researcher’s Guide, 2005).

First ESRD Service Date
The first ESRD service date (FSD) is the single most important data element in the
USRDS database, and each patient must, at a minimum, have a valid FSD. This date is used
to determine the incident year of each new patient and the first year in which the patient is
counted as prevalent. The date 90 days after the FSD is used as the starting point for most
patient survival outcomes analyses. This special rule is necessary for all ESRD patients, who
are covered by Medicare as payer, to be given a fair chance of generating Medical services
due to potential delay of the Medicare eligibility application process. Furthermore, it also
provides an adequate time window for each patient to finally settle on a stable and suitable
dialytic treatment modality. The FSD is derived by taking the earliest of the date of the start
of dialysis for chronic renal failure, as reported on the Medical Evidence form, the date of a
kidney transplant, as reported on a CMS or UNOS transplant form, a Medical Evidence form,
or a hospital inpatient claim, or the date of the first Medicare dialysis claim. Most FSDs are
derived from the Medical Evidence form. In the absence of this form, the date of the first
Medicare dialysis claim or transplantation usually supplies the FSD.

54

In the few cases in which the date of the earliest dialysis claim is earlier than the first
dialysis date reported on the Medical Evidence form, the earliest claim date is used as the
FSD. To establish the date of first ESRD service information in several data sources must be
evaluated. REBUS contains the first ESRD service date in its identification record in the
Medical Evidence record. The REBUS Quarterly Dialysis record is a summary of dialysis
billing information, and can also be used to establish first ESRD service date in the event of
missing data in other files. Finally, information on the first service date for incident
transplant patients is obtained from the UNOS transplant dataset. Data from these sources is
combined to establish the first ESRD service date (USRDS Researcher’s Guide, 2005).

Preemptive Kidney Transplantation
If the time between the date of ESRD and transplantation was 6 months or less, then
the transplant was considered to be preemptive. Otherwise, the transplant was nonpreemptive.

Incidence and Prevalence
Incidence is defined as the number of people in a population newly diagnosed with a
disease in a given time period, typically a year, while prevalence is the number of people in a
population who have the disease at a given point in time (point prevalence) or during a given
time period (period prevalence). The USRDS generally reports point prevalence, which is the
type of prevalence used primarily throughout the ADR as of December 31, 2005. Period
prevalence is reported for a calendar year. Annual period prevalent data consist both of
people who have the disease at the end of the year and those who had the disease during the
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year and died before the year’s end. The USRDS treats successful transplantation as a
therapy rather than as a “recovery” from ESRD. Patients transplanted at the time of ESRD
initiation are counted as incident patients, while those with a functioning transplant are
counted as prevalent. Because data are available only for patients whose ESRD therapy is
reported to CMS, patients who die of ESRD before receiving treatment or whose therapy is
not reported to CMS are not included in the database. The terms incidence and prevalence are
thus qualified as incidence and prevalence of reported ESRD. Some ESRD registries, such as
the European Dialysis and Transplantation Association, use the term “acceptance into ESRD
therapy.” The USRDS, however, believes that “incidence of reported ESRD therapy” is more
precise, because “acceptance” implies that remaining patients are rejected, when in fact they
may simply not be identified as ESRD cases or may not be reported to CMS. Point
prevalence is a useful measure for public health research, since it measures the current
burden of the disease on the health care delivery system, and period prevalence is appropriate
for cost analysis, since it indicates the total disease burden over the course of the year. We
have chosen, however, to focus primarily on the incidence of ESRD, believing that it is the
most useful measure for medical and epidemiological research that examines disease
causality and its effect on different sub-populations (USRDS Researcher’s Guide, 2005).

TRANSPLANT FAILURE
It is generally assumed that the graft failure date reported in the UNOS Transplant
Follow-up file or the REBUS Identification file is correct unless death or a new transplant
occur before this date. It is possible, however, for a transplant failure date to go unrecorded
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in both files. In the absence of a transplant failure date, the USRDS derives the transplant
failure date from the following sources:
•

Date of death.

•

Date of subsequent transplant.

•

The date of return to regular dialysis, indicated by a continuous period of dialysis
billing records covering a minimum of 60 days with at least 22 reported dialysis
treatments.

•

Date of return to dialysis reported on the Medical Evidence form, or the date of
graft nephrectomy from either the UNOS transplant follow-up record or a Medicare
claim.

•

If no failure date is available, then the earliest of the above dates is used as the
transplant failure date (USRDS Researcher’s Guide, 2005).
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CHAPTER 4. RESULTS

This historical cohort study investigates whether there were inequities in the
allocation of cadaver kidneys for preemptive kidney transplants (PKT) between blacks and
whites. This issue is important because PKT has established itself as an attractive alternative
to post dialysis conventional kidney transplantation (Asderakis, et al., 1998). PKT not only
avoids the risks, costs, inconvenience and diminished quality of life of dialysis but has also
been significantly associated with better graft and patient survival than transplantation after a
period of dialysis. Numerous studies have provided convincing evidence that PKT is
advantageous for patient and allograft survival (Mange and Weir, 2003). The significance to
the patients, specifically blacks, of the under utilization of PKT and the overlooked
opportunities for the avoidance of dialysis associated morbidities and improved graft and
patient survival may be substantial. The research observation that whites and persons with
higher incomes in the United States are more likely to be placed on the cadaveric waiting list
before dialysis initiation and receive a PKT might suggest some systemic bias (Kasiske, et
al., 2002). Examination of the 10,067 cadaver kidney transplant recipients that occurred
between January 1, 2000 and December 31, 2003 allowed me to determine whether there was
a disparity between blacks and whites with respect to the likelihood of their receiving
cadaver kidneys for PKT.
This investigation used descriptive statistics and multivariate analyses to identify
factors associated with whether a patient received a PKT or a conventional, post dialysis
kidney transplant. Through the examination of the descriptive statistics, a comparison of the
frequencies and percentages of PKT versus conventional post dialysis transplants between
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blacks versus whites was made. The multivariate analysis was used for the identification of
factors associated with differences that may exist and also allowed for a determination of the
statistical significance of any differences that may exist, after controlling for variables such
as age, sex, employment, primary conditions leading to ESRD and health insurance. The
conceptual framework (Fig. 3-2) guided the inclusion of variables used in the statistical
analysis. The conceptual framework reflects the relationships among the variables linking
the independent variable to the dependent variables and serves to clarify the research
problem relating to the allocation of either preemptive or conventional cadaver kidneys.
While the primary focus of this research was those transplant recipients who received
a PKT, an overview of the ESRD population was provided, because the analysis of this
population that allowed determinations as to whether the current system, policies and
practices relating to the allocation of kidneys leads to an outcome that is proportionally
reflective of the ESRD population.
The combination of the SAF, UNOS kidney transplant and the medical evidence form
files resulted in a total of 1,600,693 CMS patient records (Fig. 4-1). From the
aforementioned total, 1,513,366 of all CMS patients at least 19 years of age for the 4 year
study period were designated as having ESRD. This group was made up of 459,746
(30.38%) black and 1,053,620 (69.62%) whites. Patients were designated as having ESRD
when a physician certifies the disease on the medical evidence form (CMS 2728) or when
there was other evidence that the person has received chronic dialysis or a kidney transplant.
Of the total number of patients being certified as having ESRD during the study
period, 397,656 (92%) did not receive a transplant. Noteworthy is the fact that 151,926
(38%) of those not receiving a transplant died during the 4 year study period and only 4.5%
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CMS SAF Patient File
1,600,693

ESRD diagnosed patients
1,513,366
Black – 459,746 – (30.38%)
White – 1,053,620 – (69.62%)

ESRD 1/1/2000-12/31/2004
434,329
Black – 131,837 – (30.35%)
White – 302,555 –(69.65%)

No Transplant
Black – 125,089 (31.46%)
Died – 38,290 (30.61%)
White – 272,567 (68.54%)
Died – 113,636(41.69)

First Kidney Only Transplant
31,703
Black – 5,498 (14.34%)
White – 26,205 (86.66%)

Cadaver Transplants
10,067
Blacks – 1,962 – (19.49%)
Whites – 8,105 – (80.51%)

PKT 3,038 (30.18%)
Blacks-327-(10.67%)
Whites-2,711-(89.24%)

Lived
Black-309 (94.5%)
White-2,591 (95.58%)

Conventional 7,029 (69.82%)
Blacks – 1,635 – (23.26%)
Whites – 5,394 – (76.74%)

Died
Black-18 (5.50%)
White-120 (4.43%)

Lived
Black-1,572 (96.15%)
White-5,135 (95.2%)

Died
Black-63 (3.86%)
White-259 (4.8%)

Figure 4-1. Flow chart of patients from entry into Center for Medicare Services
System via standard analytical files through either PKT or conventional cadaver kidney
transplant.
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of those receiving a transplant died. In the group of ESRD patients not receiving a transplant
and dying during the study period 30.61% (38,290) were black and 41.69%(113,636) were
white. A total of 245,730 (61%) of those not receiving a transplant remained alive for the
duration of the four year study period.
From the total of 434,329 black and white patients at least 19 years of age diagnosed
with ESRD only 31,703 (7.45%) patients received kidney transplants during the study period.
Included in this total were recipients who received multiple transplants, living donor
transplant recipients, cadaver donor transplant recipients, preemptive, and conventional
transplant recipients. Of those in the ESRD population that received transplants only 5,498
(17.34%) were black and 26,205 (83%) were white.
Because the study period was from January 1, 2000 through December 31, 2003,
ESRD patients who were either diagnosed or had their first dialysis or transplant before
January 1, 2000, were excluded from this analysis. Patients who received a transplant
subsequent to the conclusion of the study period, December 31, 2003 were also excluded.
The total population of transplant recipients during the study period who were at least 19
years of age at the time of their first ESRD service during the study period and received their
first time only either PKT or conventional cadaver transplant during the study period was
10,067 (32.%) of the 32,703 kidney transplant recipients.
This isolated population of 10,067 cadaver transplant recipients was the sample
subjected to further analysis for this investigation. This sample was comprised of 1,962
(19.49%) black receiving cadaver transplants and 8,105 (80.51%) whites. Of the blacks
receiving cadaver transplants, 327 (11%) received a PKT and 1,635(23%) received
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conventional transplants. Among whites who received cadaver kidney transplants,
2,711(89%) received a PKT and 5,394(75%) received a conventional cadaver transplants.
As reflected in Table 4-1, the largest number of patients meeting study
inclusion/exclusion criteria came from the 2000 cohort with decreasing numbers throughout
the remaining years of the study period. Table 4-2, which shows the year and frequency of
transplants performed reflects continued increases in the number of transplants that were
performed annually. Explanations for both trends include simple increases in the number of
conventional transplants as a result of individuals spending more time on the transplant
waiting list and/or increases in the number of PKTs.

REGION OF TRANSPLANT
The transplant population examined in this investigation was distributed across the 11
organ procurement regions as defined by UNOS (Table 4-3). Most transplants took place in
region 3 which was closely followed by region 2. Region 3 led the country with most
conventional transplants and was a close second in PKTs. Approximately 25% of the PKTs
received by blacks occurred in organ procurement region 2 followed by over 20% of those
residing in region 3 (Table 4-4). Blacks in region 2 received conventional kidney transplants
at slightly lower rates, while whites received approximately the same rates of 14% for both
PKT and conventional transplants in regions 2 and 3 respectively. The cautionary
admonishment offered regarding the regional variations in cadaveric kidney transplant
frequency reflected in Tables 4-3 and 4-4 is that it is dependent on many factors, including
cadaveric organ availability, local competition for supply including ESRD prevalence, access
to the transplant evaluation process, and the relative frequencies of donor-recipient pool
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Table 4-1. Year of first ESRD service for 10,067 patients included in the current
cohort.
ESRD
Frequency
4553
3042
1764
708

Year
2000
2001
2002
2003

Cumulative Frequency
4553
7595
9359
10067

Table 4-2. Year of transplant, frequency, percentage and cumulative frequency and
percentage by year.
Year Frequency
2000
869
2001
2045
2002
3379
2003
3774

Percent
8.63
20.31
33.57
37.49

Cumulative
Frequency
869
2914
6293
10067
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Cumulative Percent
8.63
28.95
62.51
100

Table 4-3. Frequency and percentage of PKT and conventional transplant recipients
by regionb.
Region
1
2
3
4
5
6
7
8
9
10
11

Total
Frequencya
391
1468
1598
869
1064
412
1070
636
476
1014
983

PKT
Frequency
86
448
447
186
344
115
406
187
155
284
295

Conventional
Frequency
305
1020
1151
683
720
297
664
449
321
730
688

Percent (%)
3.92
14.71
16.10
8.71
10.66
4.13
10.72
6.37
4.77
10.16
9.85

a. Frequency missing = 86
b. Region 1 – CT, VT, ME, MA, NH, RI
Region 2 – DE, DC, MD, NJ, PA, WV
Region 3 – AL, AR, FL, GA, LA, MS, PR (U.S. Caribbean Islands and Virgin Islands)
Region 4 – TX, OK
Region 5 – AZ, CA, NV, NM, UT
Region 6 – AK, HI, ID, MT, OR, WA
Region 7 – IL, MN, ND, SD, WI
Region 8 – CO, IA, KS, MO, NE, WY
Region 9 – NY
Region 10 – IN, MI, OH
Region 11 – KY, NC, SC, TN, VA

64

Table 4-4. Frequencya and percentage of PKT and conventional kidney transplant
recipients by regionb and by race.
PKT
Region
1
2
3
4
5
6
7
8
9
10
11
Total

Black % (n)
5(1.60)
80(25.64)
64(20.51)
10(3.21)
19(6.09)
2(0.64)
24(7.69)
8(2.56)
22(7.05)
36(11.54)
42(13.46)
312

White % (n)
81(3.07)
368(13.93)
383(14.50)
176(6.66)
325(12.31)
113(4.28)
382(14.46)
179(6.78)
133(5.04)
248(9.39)
253(9.58)
2,641

Conventional
Black % (n)
White % (n)
38(2.32)
267(4.95)
289(17.68)
731(13.55)
375(22.94)
776(14.39)
161(9.85)
522(9.68)
80(4.89)
640(11.87)
22(1.35)
275(5.10)
142(8.69)
522(9.68)
57(3.49)
392(7.27)
79(4.83)
242(4.49)
171(10.46)
559(10.37)
221(13.52)
467(8.66)
1,635
5,393

a. Frequency missing = 86 due to missing data
b Region 1 – CT, VT, ME, MA, NH., RI
Region 2 – DE., DC, MD., NJ, PA., WV
Region 3 – AL, AR., FL, GA, LA, MS, PR (U.S. Caribbean Islands and Virgin Islands)
Region 4 – TX, OK
Region 5 – AZ, CA, NV, NM, UT
Region 6 – AK, HI, ID, MT, OR, WA
Region 7 – IL, MN, ND, SD, WI
Region 8 – CO, IA, KS, MO, NE, WY
Region 9 – NY
Region 10 – IN, MI, OH
Region 11 – KY, NC, SC, TN, VA
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biologic incompatibilities that may affect status on a given match-run Nonetheless, the
existence of these variations, whether they are real or apparent, suggests that the allocation of
organs for transplantation in the United States is not uniform across all regions.

CHARACTERISTICS OF PREEMPTIVE AND CONVENTIONAL TRANSPLANT
RECIPIENTS
Over a period of four years, January 1, 2000 through December 31, 2003, a total of
10,067 patients experienced ESRD and received primary kidney-only cadaver donor
transplants. Overall, 30.18% (3,038) of these 10,067 transplants were PKT (Table 4-5). The
remaining 69.82% (7,029) make up the conventional kidney transplant group of patients who
were transplanted after having been treated by hemodialysis or continuous ambulatory
peritoneal dialysis (CAPD) for six months or longer. Blacks accounted for 10.76% (327) of
the PKT recipients and 23.26% (1635) of the conventional transplants, with an overall rate of
19.49% (1962) of the 10,067 patients who received cadaver transplants. Whites accounted
for 89.24% (2,711) of the PKT group and 76.74% of the conventional transplant group.
Overall, whites accounted for 80.51% of the patients who received cadaver transplants during

Table 4-5. Frequency of PKT and conventional transplants occurring between
January 1, 2000 and December 31, 2003 among patients who developed ESRD during
the same time period, according to gender and race.
PKT
Black
White
327(10.76%) 2711(89.24%)
Male
56.27
57.62
Female 43.73
42.38
Total
3038 (30.18%)

Conventional
Black
White
1635(23.26%) 5394(76.74%)
59.69
63.27
40.31
36.73
729 (69.82%)
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Total

57.47%
42.53%
10,067

the study period. Overall, males (57.47%) received preemptive kidney transplants more
frequently than females (42.53%). Likewise, more males received conventional transplants
(62.44%) than females (37.56%).

Age
The mean age for all black transplant recipients in this cohort was 47.7 years of age
compared to 49.8 years of age for white transplant recipients across all groups. For all PKT
recipients the mean age was 49.1 years compared with a mean age of 48.4 years for all
conventional transplant recipients. Black PKT recipients had a mean age of 48.4 years of age
(Table 4-6) while their white PKT counterparts were almost a year older at 49.8 years of age,
indicating that, for blacks who did receive a PKT, they did so at a younger age, on average,
than did their white counterparts. Black conventional transplant recipients at an average of
47 years of age were also younger than their white conventional transplant recipient peers.
Overall, blacks received transplants at younger ages than whites. Across all groups,
transplants were more likely among recipients aged 40 through 64 (Table 4-7). At least 1
black PKT patient was over 77 years of age and 3 white PKT patients were over 82 years of
age at the time of their transplant. There was at least 1 black transplant recipient who
received a conventional kidney transplant at 79 years of age and at least 5 white transplant
recipients who were over 82 years old at the time of their transplant.

Employment
PKT recipients were more likely than conventional kidney transplant recipients to be
employed full-time (Table 4-8). It is not difficult to understand that patients who are not yet
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Table 4-6. Mean age in years of patients by race receiving either a PKT or
conventional kidney transplant between January 1, 2000 and December 31, 2003.
Transplant
Type
Preemptive

Black
White

N
327
2711

Mean ( yr)
48.4
49.8

Std. Error (yr)
0.69
0.23

1635
5394
10,067

47.0
49.9

0.31
0.17

Conventional
Black
White
Total

Table 4-7.
Age category at first ESRD service and kidney transplant frequency
included in the current cohort.
Age Category
19
20-24
25-29
30-34
35-39
40-44
45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84

Frequency
43
272
467
731
888
1123
1441
1541
1350
1102
734
290
76
9
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Percent(%)
0.43
2.70
4.64
7.26
8.82
11.16
14.31
15.31
13.41
10.95
7.29
2.88
0.75
0.09

Table 4-8. Employment status in percentages of PKT and conventional transplant
recipients by race.
PKT
Current
Employment
Status
Unemployed
Employed
Full-Time
Employed
Part-Time
Homemaker
Ret-Age
Ret-Disab
Med LOA
Student

Black
(n = 226)

White
(n = 2,037)

Conventional
Black
White
(n = 1,541)
(n = 5,127)

42(18.58)

337(16.54)

397(25.76)

878(17.13)

79(34.96)

756(37.11)

441(28.62)

1,566(30.54)

4(1.77)
3(1.33)
25(11.06)
43(19.03)
24(10.62)
6(2.65)

114(5.60)
96(4.71)
234(11.49)
321(15.76)
166(8.15)
13(0.64)

54(3.50)
31(2.01)
158(10.25)
305(19.79)
137(8.89)
18(1.17)

232(4.53)
236(4.60)
740(14.43)
1,055(20.58)
380(7.41)
40(0.78)
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on dialysis may be better able to work full-time, because dialysis can make it difficult to
maintain full-time employment. Another potential advantage of PKT may be allowing at
least some individuals to continue to work. White PKT recipients were more likely to be
employed full-time at 37.11% (756) compared to 34.96% (79) for blacks. Black PKT
patients were slightly more likely to report being unemployed at 18.58% (42) when
compared to white PKT recipients at 16.54% (337). White PKT recipients also reported
higher rates of part-time employment 5.60% (114), being homemakers 4.71% (96), and being
retired at 11.49% (234) than did black PKT recipients. Black patients did have higher
percentages of retired disabled at 19.03% (43), those on medical leave of absence at 10.62%
(24) and students at 2.65% (6). Black conventional kidney transplant recipients reported
being unemployed at a rate much higher than that of white conventional transplant recipients
25.76% (397) compared to 17.13% (878) for whites. Whites reported higher rates of
employment, 30.54% (1566), part-time employment, 4.53% (232), being homemakers,
4.60% (236), being of retirement age, 14.43% (740), and retirement disabled at 20.58%
(1055) and students at 1.17%. For black conventional kidney transplant recipients
unemployment, 25.76% and those on a medical leave of absence, 8.89%, were the only
categories in which the percentages of blacks exceeded those of whites. There were not any
differences in employment status between blacks and whites for either PKT or conventional
recipients.

CAUSES OF ESRD
Overall, the leading cause of ESRD for this cohort was diabetes, followed by
hypertension (renal disease caused by hypertension with no primary renal disease),
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glomerulonephritis, and cystic kidney disease (Table 4-9). In the black PKT population, the
causes listed as leading to ESRD were diabetes 21.71% (71) and hypertension 19.88% (65)
and for black conventional kidney transplant recipients both diabetes 34.43% (563) and
hypertension 32.42% (563) remained the leading causes of ESRD. In white PKT patients the
leading causes of their ESRD were diabetes at 30.51% (827), glomerulonephritis 13.32%
(361), and cystic kidney disease 13.24% (359). In white PKT patients hypertension was
listed as the cause of ESRD for only 7.49% (203) of the recipients. For white conventional
transplant recipients diabetes remained the dominant cause of ESRD at 39.19% (2114) with
glomerulonephritis remaining second at 20.47% (1104). There were differences between the
PKT recipients and the conventional transplant recipients across the 3 major causes of ESRD,
diabetes, hypertension and glomerulonephritis.

KIDNEY DONOR RACE
Overall 89.24% (n=2,711) of the donor kidneys received by PKT recipients and
76.74% (n=5,394) of those received by conventional transplant recipients were obtained from
white cadaver donors (Table 4-10). Black PKT patients received 69.42% (n=227) of their
kidneys from white donors and 17.43% (57) from blacks. White PKT patients received
5.94% (161) from black donors with the bulk of their PKT donations (77.61% (n=2,104)
coming from other white donors. Among the 1,635 black conventional transplant recipients,
16.39% (n=268) of the kidneys came from black donors and 68.87% (n=1,126) came from
white donors. Black donors were responsible for 5.82% (n=314) of the organ donations to
whites, with other whites contributing 77.29% (n=4,169). More black cadaver donor kidneys
were transplanted into whites than into black kidney recipients. Thus despite a greater
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Table 4-9. Primary disease causes of ESRD in frequency and percentages of PKT and
conventional kidney transplant recipient, by race.
PKT
Primary Disease
Category
Diabetes
Hypertension
Glomerulonephritis
Cystic Kidney
Other Urologic
Other cause
Unknown Cause
Missing Cause

Black
n=327
(10.76)
71(21.71)
65(19.88)
45(13.76)
21(6.42)
20(6.12)
32(9.79)
15(4.59)
58(17.74)

White
n=2,711(89.24)
827(30.51)
203(7.49)
361(13.32)
359(13.24)
130(4.80)
351(12.95)
148(5.46)
332(12.25)

Conventional
White
Black
n=5,394
n=1,635(23.36)
(76.74)
563(34.43)
2,114(39.19)
530(32.42)
699(12.96)
301(18.41)
1,104(20.47)
56(3.43)
662(12.27)
18(1.10)
153(2.84)
98(5.99)
482(8.94)
67(4.10)
179(3.32)
2(0.12)
1(0.02)

Table 4-10. Kidney donor race in frequency and percentages of PKT and conventional
kidney only transplant recipients.
PKT
Donor Race
Asian
Black
White
Other/Unknown

Black
(n=218)
4(1.22)
57(17.43)
227(69.42)
39(11.93)

White
(n=2,331)
31(1.14)
161(5.94)
2,104(77.61)
394(14.86)
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Conventional
Black
White
(n=582)
(n=5,295)
19(1.16)
72(1.33)
268(16.39)
314(5.82)
1,126(68.87)
4,169(77.29)
221(13.52)
823(15.26)

percentage of the kidneys from black donors being transplanted into white recipients, the
overwhelming majority of the available organs were obtained from white donors.

PATIENT OUTCOMES FOR PKT AND CONVENTIONAL KIDNEY TRANSPLANT
RECIPIENTS
The association among race, PKT, conventional kidney transplantation, and outcomes
were analyzed based on four measures assessed on December 31, 2003: alive with
functioning graft, alive without functioning graft, died with a functioning graft and died after
graft loss (Table 4-11). Among black recipients those alive with functioning grafts from
either PKT or conventional transplants, were 81.65% and 84.04%, respectively. There was a
slightly higher percentage of black conventional kidney transplant recipients alive with
functioning grafts than there were PKT recipients. For those alive without functioning grafts
blacks had approximately 12% of both PKT and conventional kidney transplant recipients.
Fewer blacks with a PKT died after graft loss, 0.92% than did conventional kidney transplant
recipients with 1.35%. However, the percentage of PKT blacks that died with a functioning
graft, 4.59%, was more than that of blacks with conventional kidney transplants (2.51%).
As was the case with blacks, whites with conventional kidney transplants had a
slightly better percentage of those surviving with a functioning graft than did the PKT
recipients. More PKT whites survived with graft loss than did white conventional kidney
transplant recipients but fewer white PKT recipients died after graft loss (0.63%) than did
conventional kidney transplant recipients (1.11%). A slightly larger percentage of white
PKT recipients died with a functioning graft (3.80%) than did white conventional kidney
transplant recipients (3.69%).

73

Table 4-11. Percentages and frequencies for various outcomes for patients receiving a
PKT or conventional transplanta.

Outcome

PKT b
Black
White
(n=327)
(n=2711)
267(81.65)
2,356(86.91)

Alive with
functioning graft
Alive with graft
42(12.84)
loss
Died after graft loss 3(0.92)
Died with
15(4.59)
functioning graft

Conventionalc
Black
White
(n=1635)
(n=5394)
1,374(84.04)
4,722(87.54)

235(8.67)

198(12.11)

413(7.66)

17(0.63)
103(3.80)

22(1.35)
41(2.51)

60(1.11)
199(3.69)

a. The cohort consisted of all patients who experienced ESRD and/or received a cadaver
kidney transplant between January 1, 2000 and December 31, 2003.
b. No significant difference was detected between blacks and whites with respect to the 4
outcome groups (p<.0615).
c. A significant difference was detected between blacks and whites with respect to the 4
outcome groups (p<.0001).

74

A larger proportion of white PKT recipients (86.9%) lived with functioning grafts
compared to black PKT transplant recipients (81.65%); however, a larger proportion of black
PKT recipients were alive after graft loss (12.84%) compared to white PKT recipients
(12.11%). A smaller proportion of white PKT recipients died after graft loss (0.63%) than
black PKT recipients (0.92%). A larger proportion of blacks PKT recipients died with a
functioning graft (4.59%) than did white (3.80%) PKT recipients. Outcomes for white
conventional kidney transplant recipients were similar to those of the PKT group with the
marked exception of those who died with a functioning graft. White conventional kidney
transplant recipients died with greater frequency (3.69%) when compared to blacks
conventional transplant recipients (2.51%).

TIME TO TRANSPLANTATION
For the 327 black PKT recipients the median elapsed time from first service for
dialysis to transplantation was 1 day (mean ± se: 1.0894 ± 0.0966 months) compared to black
conventional transplant recipients whose median elapsed time was 22.47 months (mean ± se:
23.2178 ± 0.25 months). The mean time for the 2711 white PKT recipients was, as it was
with the PKT blacks, 1 day (mean ± se: 1.0941 ± 0.0342 months). White conventional
kidney transplant recipients had a median elapsed time of 18.29 months (mean ± 19.7203 ±
0.1261 months) (Table 4-12). Although black and white PKT recipients both had a median
elapsed time of 1 day as their elapsed time from first service for dialysis and their kidney
transplant, there was a difference of approximately 4 months waiting time between blacks
and whites receiving conventional kidney transplants.
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Table 4-12. Racial disparity in elapsed time from first service for dialysis and
transplantation.
Type
Transplant
Preemptive

Mean (Mo)

Median
(Mo)

Std. Error
(Mo)

327
2711

1.09
1.09

0.032
0.32

0.09
0.03

1635
5394

23.21
19.72

22.47
18.29

0.24
0.12

Race

No. of
Patients

Black
White
Black
White

Conventional

MULTIVARIATE ANALYSIS
For all cadaver transplant recipients in the study cohort, the odds of receiving a
preemptive kidney transplant were 2.5 times greater for whites than for blacks (Table 4-13).
This result was statistically significant. For this same cohort the odds of receiving a
preemptive kidney transplant were 23% greater for females compared with males. This result
was also statistically significant. Compared with those patients who had a diagnosis of
hypertension as the primary cause for their ESRD, a patient was more than twice as likely to
receive a preemptive transplant if they had a diagnosis that indicated that their ESRD was
primarily caused by something other than hypertension. Compared to patients who had a
diagnosis of diabetes as the primary cause of their ESRD, those who did not have that
diagnosis had a 46% greater likelihood of getting a preemptive kidney transplant. Compared
with patients who had a diagnosis of glomerulonephritis as the primary cause of their ESRD
those patients who did not have that diagnosis had a 62% greater likelihood of getting a
preemptive kidney transplant.

76

Table 4-13. Recipient characteristics associated with preemptive kidney
transplantationa.
Variable
Black

Reference Group
White

Female

Male

Not-Hypertension

Hypertensionb

Not-Diabetes

Diabetesb

NotGlomerulonephritis

Glomerulonephritisb

Odds Ratio
(95% CI)
0.3979
(0.35 to 0.45)
1.230
(1.12 to 1.34)
2.190
(1.90 to 2.51)
1.465
(1.33 to 1.60)
1.619
(1.43 to 1.82)

P value
<0.0001
<0.0016
<0.0001
<0.0001
<0.0001

a. Odds rations and confidence limits were estimated from 2x2 contingency tables.
b. As the cause of ESRD.

Although the analysis reflected in Table 4-13 shows race and other variables are
significantly related to receiving a PKT, the analysis must be carried further to demonstrate a
disparity. These differences reflected at this point do not demonstrate a disparity between
blacks and whites in the rates in which they receive PKTs. In a broad context, we think of
health disparities as the population specific differences in the presence of disease, health
outcomes or access to health care. Health Disparities, as defined by the Institute of
Medicine’s Committee on Understanding and Eliminating Racial and Ethnic Disparities in
Health Care, are racial and ethnic differences in the quality of health care that are not due to
access-related factors or clinical needs, preferences, or appropriateness of the intervention
(IOM, 2003).
Although every member in the cohort had access to Medicare they all did not use
Medicare for their ESRD treatment and/or transplant. All insurance is not the same
insurance. That is to say that all insurance does not afford the same level of access.
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Therefore to determine if there was a true disparity between blacks and whites in PKT it is
necessary to control for access in order to balance the variables that may give one group an
advantage over the other in access to PKT. To do so, a subset of the cohort (n=847)—only
those utilizing Medicare Parts A and B—was subjected to the multivariate analysis in order
determine if the significance of the aforementioned variables goes further to demonstrate
that there was actually a disparity between blacks and whites relative to receipt of PKT
(Table 4-14). As reflected in Table 4-14 race and the aforementioned comorbid conditions
of hypertension, diabetes, and glomerulonephritis remained statistically significant, similar to
the findings reported in Table 4-13. For those in the subset cohort, the odds of receiving a
preemptive kidney transplant were almost 60% less likely for blacks than for whites (Table
4-14). Those in this subset cohort had 15% greater odds for a PKT if they were females
compared to males, which was a lower odds ratio than in the overall cohort. Compared with
those patients who had a diagnosis of hypertension, diabetes or glomerulonephritis as the
primary cause for their ESRD a patient had 80%, 50%, and 24% respectively greater odds of
getting a preemptive transplant if they had a diagnosis that indicated that one of these was not
the primary cause of their ESRD.
A second strategy was used to again control for the role of access in PKT receipt.
The full cohort was subjected to a final expanded multivariate analysis, which included two
insurance variables—those with Medicare, both parts A and B—and those with Medicare as
the secondary payer (Table 4-15). The employment variable was also included in this
analysis to test for its effect on the likelihood of receiving a PKT. These results remained
consistent with the previous two analyses (Tables 4-13 and 4-14) with race, hypertension,
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Table 4-14. Medicare A and B only recipient characteristics associated with preemptive
kidney transplantation.
Variable
Age 40 to 55

Reference
Group
Age > 55

Black

White

Female

Male

Non-Hypertension

Hypertension

Non-Diabetes

Diabetes

NonGlomerulonephritis

Glomerulonephritis

Odds Ratio
(95% CI)
1.000
(0.989 to 1.010)
0.4294
(0.2945 to 0.6261)
1.1474
(0.8671 to 1.5184)
1.8050
(1.2095 to 2.6973)
1.4976
(1.1177 to 2.0065)
1.2415
(0.8544 to 1.8042)

P value
0.9508
0.0002
0.5322
<.0001
<.0001
0.0002

Table 4-15. Recipient characteristics associated with a preemptive kidney
transplantation with employment and Medicare A and B as primary payer and/or
Medicare as a secondary payer included in the model.
Variable
Age 40 to 55

Reference
Group
Age > 55

Black

White

Female

Male

Not-Hypertension

Hypertension

Not-Diabetes

Diabetes

NotGlomerulonephritis
Employed

Glomerulonephritis

HMO and other

Medicare A and B
only
Medicare Secondary

HMO and other

Odds Ratio
(95% CI)
0.999
(0.995 to 1.003)
0.460
(0.403 to 0.526)
1.142
(1.042 to 1.252
3.003
(2.598 to 3.541)
2.354
(2.120 to 2.615
2.733
(2.391 to 3.125)
1.133
(1.024 to 1.254)
2.204
(1.966 to 2.471)
1.800
(1.610 to 2.013)

Not-Employed
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P value
0.0122
<.0001
0.0044
<.0001
<.0001
<.0001
0.0153
<.0001
<.0001

diabetes and glomerulonephritis, reflecting the statistically significant relationships they had
with PKT in the two aforementioned analyses. Employment did not show a statistically
significant relationship and appears to have no direct effect on whether blacks or whites
receive PKT. However, insurance, both Medicare A and B and Medicare as a secondary
payer did show statistical significance. The interpretation of the statistical significance of
insurance is that those not covered by Medicare A and B are almost more than twice as likely
to receive a PKT as those covered by Medicare A and B. Those not covered by Medicare as
a secondary payer were more than 80% more likely to receive a PKT as those covered by
Medicare A and B. This finding is supported in reflecting back on the subset used to develop
the cohort analyzed in Table 4-14. There were only 847 patients identified from the overall
cohort of 10,067 (8.4%) identified as those on Medicare A and B insurance. Of those 847
patients identified in the subset there were 43 black PKT recipients which constituted 5.08%
of those on Medicare A and B only, but .03% of the overall cohort.
When these five independent predictors of receiving a PKT in the analysis of the full
cohort, (Table 4-14) were included: black race ( [OR] = 0.46, reference: white, i.e., whites
46% greater odds to receive a PKT than blacks); female (OR =1.16 reference: male; i.e.,
females 16% more likely to receive a preemptive kidney transplant than males); nonhypertensive (OR = 3.25, reference: hypertension) those without hypertension as the primary
cause of ESRD were more than 3 times more likely to receive a PKT); non-diabetics (OR =
2.45, reference: diabetes), those without diabetes as the primary cause of ESRD were more
than 2 time more likely to receive a PKT; non-glomerulonephritis (OR =2.82; reference:
Glomerulonephritis, those without glomerulonephritis as the primary cause of ESRD were
more than 2 times more likely to receive a PKT).
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Subsequent analysis limiting the scope to a subset of the overall cohort to those who
had Medicare A and B insurance (Table 4-14) only produced similar results to the analysis
of the overall cohort. Race, diabetes, hypertension and glomerulonephristis remained
statistically significant. A final analysis of the overall cohort that also included employment
and Medicare A and B as the primary insurance and those who had Medicare as a secondary
payer (Table 4-15) also produced similar results in that race remained significant as did
diabetes, hypertension and glomerulonephritis. Employment, was also statistically
significant in its relationship or a predictor of whether someone receives a PKT. Medicare A
and B as the primary insurance and those who had Medicare as a secondary payer each did
reflect statistical significance as indicators of being less likely for those patients with
Medicare A and B and/or those patients with Medicare as a secondary insurance to receive a
PKT.
The overall hypothesis of this research is that the distribution of PKT is not equitable
and this inequity is to the detriment of blacks. First, as this research points out there are clear
differences between blacks and whites in PKT rates. Secondly and most importantly this
research demonstrates that not only are there differences but that a true disparity exist in the
allocation of PKT between blacks and whites. Thus this research indicates that the leading
causes of ESRD in blacks and whites who received PKTs was diabetes (22%) and (31%)
respectively. Black conventional transplant recipients had higher rates of hypertension and
diabetes than did black PKT recipients overall. White conventional kidney transplant
recipients had the highest rates of diabetes (39.19%) of all groups. Of all PKT recipients
blacks received 10.76% compared to 89.24% received by whites. The mean age for blacks
receiving PKTs was 48.4 years of age compared to 47 years of age for black conventional
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kidney transplant recipients. The mean age for whites, both PKT and conventional transplant
recipients was approximately 49 years of age. Higher percentages of PKTs took place in the
northeastern and southeastern regions (UNOS regions 2 and 3) of the United States. The
majority of PKT recipients (both blacks and whites) received their donor organs from whites.
Blacks received 69.42% white donor organs compared to 77.61% received by whites. Blacks
did receive 17.43% of their donor organs from blacks, with whites receiving approximately
6% of their organs from blacks. For those receiving PKTs during the study period, 86% of
whites and 81% of blacks were alive with functioning grafts.

82

CHAPTER 5. CONCLUSION

There remain unexplained differences between blacks and whites in receiving both
PKT and non-PKT. It has been suggested that these differences may be the result of
institutional racism. Indeed the Institute of Medicine concluded in its recent report on the
racial and ethnic disparities in health care that “although a myriad sources contribute to these
disparities, some evidence suggests that bias, prejudice, and stereotyping on the part of health
care providers may contribute to differences in care” (IOM, 2002).
From this analysis it is concluded that a disparity does exist in the allocation of PKTs
between blacks and whites. This research advances this body of literature in that it narrows
the scope of the 2002 work of Kasiske, et al. to focus on cadaver donor kidneys, which
exposes the vulnerabilities of the UNOS waiting list in its roll in the allocation of cadaver
donor kidneys and at the same time serves to highlight the problems with the kidney
evaluation process. Most importantly, this research serves to clearly articulate the disparity
between blacks and whites in the allocation of PKTs. Above and beyond other research that
included both living and cadaver kidneys in their analysis, this research focused on cadavers
only and instead of limiting the scope to pointing out difference and odds ratio relating to
those differences in this research access was controlled for by limiting the analysis to those
with Medicare A and B only and still being able to identify the statistical significance of race.
This analysis, by controlling for access, was able to state emphatically that there is disparity
in the allocation of PKT between blacks and whites. This disparity reflects an inequality in
the allocation of cadaver kidneys.
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In the United States, we believe that health care should be fairly distributed by race,
ethnicity, socioeconomic status, or geographic location. When unfair differences exist, they
are referred to as disparities. It is important to understand that differences in race and
ethnicity will always exist; it is wrong, however, when these differences lead to unequal care.
The specter of health disparities represents an egregious failure of the medical community in
the United States (Young & Kew, 2005). Despite the unprecedented explosion in scientific
knowledge relating to kidney transplantation and the phenomenal capacity of the transplant
process and the immunosuppression medications to balance the matching issues related to
kidney transplants, blacks have not benefited fully or equitably from the fruits of this science
or from those systems responsible for the equitable allocation of cadaver kidneys. Despite the
efforts here and in other research, the reasons for the disparities in both PKT and
conventional kidney transplant recipients are not fully understood. It is likely, however, that
the complete picture incorporates a complex interaction between socio-cultural, genetic, and
environmental factors. As reflected in Fig. 5-1, the IOM (2003) identifies the operation of the
health care system, the legal and regulatory climate in which health care takes place, and/or
the biases and prejudices that come with discrimination, prejudice, and stereotyping, and
factors that may contribute to the disparities reflected in PKT and other health care dynamics.
In this country, blacks are much less likely than whites to be referred to nephrologists
and undergo renal transplantation in a timely manner (Kausz, et al., 2000). Race has
historically been a factor that is reflected in the literature as having an influence on access to
general health care in the United States. Non-minorities enjoy a better quality of health care
than do minorities. In trying to understand disparities a spectrum of possibilities offers
possible explanations. Disparities between minorities and non-minorities may be the
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Figure 5-1. Differences, disparities, and discrimination: Populations with equal access
to health care.
Source: Smedley, I., Stith, B.D., Nelson, A.R. Institute of Medicine (U.S.). Unequal
Treatment Committee on Understanding and Eliminating Racial and Ethnic Disparities in
Health Care. National Academies Press, 2003. Reprinted with permission.

unintended consequences of the operation of the health care system and the legal and
regulatory climate or it may be as a result of discriminatory bias or stereotyping (Fig. 5-1).
The discrepancy between blacks and whites with respect to PKT is multifaceted and
is influenced by several factors that dictate how the PKT and conventional transplant process
unfolds. It is disparities like those outlined in this research and others that prompted
Congress to request an Institute of Medicine (IOM) study committee to assess differences in
the kinds and quality of health care received by minorities when compared to non-minorities.
While the study committee did not focus specifically on PKT or conventional kidney
transplantation they did define disparities in health care as racial or ethnic differences in the
quality of health care that are not due to access related factors or clinical needs, preferences,
and appropriateness of intervention. The committee’s analysis was focused at two levels: 1)
the operation of health care systems and the legal and regulatory climate in which health
systems function; and 2) discrimination at the individual, patient-provider level.
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Discrimination, as the committee uses the term, refers to differences in care that result from
biases, prejudices, stereotyping, and uncertainty in clinical communication and decisionmaking (Smedley, Stith, & Nelson, 2003). While discrimination at the patient level can
never be dismissed, a type of discrimination that is more subtle is institutional discrimination.
This refers to policies, procedures, and practices that may appear to be neutral, but the end
result is uneven access by group membership to resources, status and power (IOM, 2003). It
is the perspective of this research that the systemic failures of the health care system and
lesions in the health policy, legal and regulatory climate that contribute significantly to the
disparities in the allocation of PKT between blacks and whites.
Despite the lower percentages of black patients in this study receiving PKT and the
lower percentages of PKT reflected in other research, Weng and Mange (2003) indicated that
patients who underwent the PKT evaluation process overwhelmingly (75%) indicated a
desire to receive a transplant before initiation of maintenance dialysis. This was consistent
with their stated negative impressions of their anticipated quality of life on dialysis.
However, despite the preferences expressed by these patients and the commencement of the
transplant evaluation process preemptively, the disparity in PKTs for blacks still exists.
Although this disparity may stem from the complexity of modern medical care, which
requires access to physicians, proper diagnosis of renal disease, comprehension by the patient
of their disease, and referral to a nephrologists and then to a transplant center (Weng &
Mange, 2003) PKT remains a preferred option that requires that the transplant evaluation
occur preemptively.
Correcting any inequities in PKT will no doubt require substantial effort on the part
of those who care for patients with kidney disease, and especially those who refer them for
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transplant evaluation (Kasiske et al., 2002). One critical element in addressing PKT is to
ensure black patients are referred to nephrologists and transplant centers relatively early in
the course of progressive renal disease (Kausz, et al., 2001), because late referral to
nephrology care, when the need for renal replacement therapy is imminent, is associated with
increased mortality rates (Stack, 2003) and decreased rates of PKT and conventional
transplants. Individuals can only be evaluated with sufficient lead-time to undergo PKT if
patients as well as physicians are educated about the detection and recognition of
asymptomatic renal disease and the benefits of early referral to a nephrologist. This will
require more extensive education about utilizing valid formulae to provide an age, gender
and race adjusted estimated GFR. (Mange & Weir, 2003). Nephrologists should discuss the
advantages of PKT with the patients and advocate that these individuals present to a
transplant center for evaluation, even at the expense of diminishing the nephrologists’
dialysis population and subsequent reimbursement for providing dialysis care (Ayanian, et
al., 1999).
As this research points out, individuals with primary causes of ESRD, such as
diabetes and hypertension were significantly less likely to receive a PKT. Diabetes and
especially hypertension tend to affect blacks at higher rates and promote ESRD. The rate at
which blacks develop CKD and ultimately reach ESRD will most certainly not change unless
the medical community can educate blacks and other minorities on how to take charge of
their health by adopting healthy lifestyles that are likely to ameliorate the tendency toward
obesity, diabetes, and hypertension. As the results of this research reflects, for blacks
diabetes is the underlying cause of ESRD for 22% of all PKT transplant recipients and 34%
of all conventional transplant recipients. Hypertension was the primary cause of ESRD for
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19% of all PKT and 32% of all black conventional kidney transplant recipients. These
results support other research that indicated that diabetes and/or hypertension was the
primary cause of ESRD in 70% of all new ESRD cases (Young and Kew, 2005). Diabetes is
nearly 50% more prevalent in blacks than in whites and the pattern of hypertension among
blacks in the U.S. is unique and remains the leading cause of ESRD for all ages. Odds ratios
from this research show that those without diabetes or hypertension as the primary cause of
their ESRD are 2 and 3 times, respectively, higher odds of getting a PKT. Based on these
primary causes of ESRD the likelihood of receiving a PKT for blacks is diminished
significantly. In order to change the downstream possibilities of increasing the rates at which
blacks receive PKT the cormobid conditions that are shown to diminish the likelihood of
receiving a PKT must be addressed. This research says that independent of these disease
states, being black also affects whether an ESRD patient will receive a PKT or not.

DISPARITIES IN PKT, UNOS, AND THE HEALTH POLICY IMPLICATIONS
The UNOS waiting list was designed as a just and equitable system through which a
limited number of organs are allocated to the thousands of Americans in need of a transplant.
People on the waiting list continue to trust the system because of the belief that everyone on
the list has an equal opportunity to receive a kidney and that allocation is blind to practices
and policies that have the potential to be exploited. Policies that allow or permit the
manipulation of the waiting list in any way are not only unethical but challenge the integrity
of the UNOS system (Zink, et al., 2005). Preemptive transplantation when someone has not
spent a significant amount of time on the waiting list is either a direct contradiction of the
clearly articulated UNOS policy that one accumulates points for time on the waiting list or a
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practice that is carried out under the guise of a policy variance, alternative allocation or
distribution exception, or what is identified as the committee-sponsored alternative system
provisions of the UNOS policies. Such options within the organ allocation policies are in
theory designed for the purpose of increasing organ availability and/or organ quality, and
allowing the latitude to subjectively reduce or address an inequity in organ
allocation/distribution unique to the local area, and/or examining a policy variation intended
to benefit the allocation/distribution system overall.
As this research has shown, virtually all the preemptive kidney recipients experience
a lapse time of one day from their first ESRD service and transplantation. While this does not
automatically mean that these individuals spent less time on the waiting list than all other
potential recipients, it does lend itself to the possibility that significant numbers of predialysis patients are being placed on the waiting list earlier and more often in certain regions
of the country than in others.
The UNOS organ allocation protocols have numerous shortcomings and as a result of
the demand for a scarce resource continues to grow those waiting become desperate and look
for ways to circumvent policies that govern the waiting list. It could be argued, this is what
is being done in order to get the population for preemptive kidney transplants. By
subjectively placing patients on the waiting list at various stages of renal failure the process
of organ allocation will remain inequitable. In a system with such limited resources, an
advantage obtained by one person directly causes the disadvantage of another (Zink, et al.,
2005).
UNOS and the medical community have agreed that the most effective and ethical
way to allocate organs is through a balance of the principles of equity and utility. According
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to the principle of equity as outlined by Zink, et al., (2005) once placed on the UNOS waiting
list, every member of the list should have an equal chance of receiving a much needed organ.
Allocation of organs through the principles of utility should result in the prioritization of
organs to the best candidates in the most need (Zink et al., 2005). Striking the balance
between the two principles can never be done through the subjective application of the
UNOS policies currently in effect. Practices such as solicitation for organs, directed
donation, multiple listing or preemptive kidney transplantation were never intended to allow
people to gain an unfair advantage. Regardless of the intent of such practices each of them
has inherent within it the potential for abuse.
In 2003, UNOS modified the allocation algorithm to eliminate points for HLA
matching but continues to allow for local variances based on the concept of acceptable
mismatches that at least theoretically, preserve the benefits of matching while offering more
equitable allocation (Takemoto, et al., 2000). In light of the increasing recognition of the
influence of non-immunologic factors on long time survival, this is yet another opportunity
for the subjective abuse of the organ allocation decision making process. Given all the
subjective latitude built into the allocation policies it may be time to formulate a completely
new paradigm for organ allocation.

FUTURE RESEARCH CONSIDERATIONS
The continued examination of UNOS policies is an absolute necessity in ongoing
efforts to ensure the just and equitable allocation of kidneys and for a system to avoid the
exploitation by those who are forced to resort to desperate measures during desperate times.
The growing gap between the demand for lifesaving organs and their availability as reflected
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during this study leaves thousands waiting for an organ and thousands more to die before a
kidney can be allocated to them. Hence the compelling need to improve the system of organ
procurement and allocation

Socioeconomic status is routinely identified in the literature as

having an impact on whether someone gets kidney transplant or not (Young & Kew, 2005).
Although a significant number of poorer members of the majority population are clearly
present in all parts of the United States, the number of blacks with incomes below the federal
poverty level is fourfold greater than the number of whites at this level (Young & Kew,
2005). As a result, blacks are much more likely to be dependent on public assistance
programs such as Medicare and Medicaid for health insurance and medication coverage. As
Kasiske, et al. (2002) pointed out in their study the primary source of payment was the
strongest correlate of PKT. Kasiske’s research supports (Table 4-15) that patients who had
Medicare as the primary payer or as a secondary payer were much less likely to receive
preemptive transplants.
Kasiske’s study (2002) as does this study conceded the point that it was probable
Medicare may be a surrogate for other socioeconomic factors. As the authors go on to point
out that even though Medicare may eventually cover the cost of transplantation, the
significant expenses that may be incurred before qualifying for Medicare may be prohibitive
for may patients who could otherwise be candidates for PKT. In another study Kasiske, et al.
(1998) points out those patients who have suboptimal insurance coverage may be more likely
to fail to keep initial appointments with the transplant center, due to concerns about cost and
payment. According to Kasiske et al. (1998) others have found that race and socioeconomic
factors influence health care utilization even when there is adequate insurance coverage
(Gornick, et al., 1996). As pointed out in this research, when insurance coverage is equal
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(Table 4-15) race and perhaps unidentified socioeconomic factors and institutional systems
still lead to differences in PKT rates. Overcoming socioeconomic barriers to health care is
not simply a matter of insurance coverage. Given that Medicare covers the cost of
transplantation, preemptive and conventional, it is possible that removing the pre-transplant
disincentives by expanding Medicare coverage to make PKT more accessible to those limited
to Medicare coverage that blacks may experience increased PKT rates. Further evaluation of
the impact of Medicare on the ESRD population specifically relating to receipt of PKT needs
to be undertaken.
The benefits of PKT are well documented in the literature; however, the benefits of
PKT are not shared equally among transplant recipients. This research validates the
perceptions of the inequities in the allocation of both preemptive and conventional cadaver
kidney transplants. This validation of that perception of inequity threatens the very
foundation upon which our system of altruistic organ donation is built. In a global society
that prides itself on a high level of sensitivity and equality, there is an ethical and moral
imperative to address the continuing racial/ethnic disparities in PKT and the many factors
that are potentially underlying this disparity. Given the rising demand for kidney
transplantation within a setting of scarce resources, the economic and ethical dimensions of
transplant medicine are of increasing interest and importance to patients, providers and
payers. Continued research in this area focusing on health policy and practice adaptations
will assist in uncovering ways to maximize use of PKT in an ethical and cost-effective
manner that ultimately results in reduced cost to the ESRD program and the prolonging and
improvement in the quality of many lives. A specific example would be primary care policy
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changes mandating the screening of hypertensive blacks for declining kidney function so that
priority consideration could be given for PKT.
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